{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:35:45Z","timestamp":1790253345371,"version":"4.1.0"},"reference-count":225,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Microbiol"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s00203-025-04277-4","type":"journal-article","created":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T16:34:22Z","timestamp":1740846862000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["From protein to immunology: comprehensive insights into Marburg virus vaccines, mechanism, and application"],"prefix":"10.1007","volume":"207","author":[{"given":"Mohamed J.","family":"Saadh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3582-2645","authenticated-orcid":false,"given":"Faris Anad","family":"Muhammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafid Jihad","family":"Albadr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Sanghvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Renuka","family":"Jyothi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayank","family":"Kundlas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamal Kant","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surat","family":"Gulyamov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waam Mohammed","family":"Taher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariem","family":"Alwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmood Jasem","family":"Jawad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali M. Ali","family":"Al-Nuaimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,1]]},"reference":[{"issue":"1","key":"4277_CR1","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1080\/21505594.2022.2054760","volume":"13","author":"MH Abir","year":"2022","unstructured":"Abir MH, Rahman T, Das A, Etu SN, Nafiz IH, Rakib A et al (2022) Pathogenicity and virulence of Marburg virus. Virulence 13(1):609\u2013633","journal-title":"Virulence"},{"issue":"Suppl 3","key":"4277_CR2","doi-asserted-by":"publisher","first-page":"S796","DOI":"10.1093\/infdis\/jir312","volume":"204","author":"J Adjemian","year":"2011","unstructured":"Adjemian J, Farnon EC, Tschioko F, Wamala JF, Byaruhanga E, Bwire GS et al (2011) Outbreak of Marburg hemorrhagic fever among miners in Kamwenge and Ibanda Districts, Uganda, 2007. J Infect Dis 204(Suppl 3):S796\u2013S799","journal-title":"J Infect Dis"},{"issue":"10","key":"4277_CR3","doi-asserted-by":"publisher","first-page":"505","DOI":"10.52403\/ijhsr.20241055","volume":"14","author":"SK Ahamad","year":"2024","unstructured":"Ahamad SK, Laxmi RV, Kumar AR (2024) mRNA vaccines: transforming disease prevention for the modern era. Int J Health Sci Res 14(10):505\u2013515","journal-title":"Int J Health Sci Res"},{"key":"4277_CR4","doi-asserted-by":"publisher","first-page":"5560605","DOI":"10.1155\/2023\/5560605","volume":"2023","author":"FF Albaqami","year":"2023","unstructured":"Albaqami FF, Altharawi A, Althurwi HN, Alharthy KM, Qasim M, Muhseen ZT et al (2023) Computational modeling and evaluation of potential mRNA and peptide-based vaccine against Marburg virus (MARV) to provide immune protection against hemorrhagic fever. Biomed Res Int 2023:5560605","journal-title":"Biomed Res Int"},{"key":"4277_CR5","doi-asserted-by":"publisher","first-page":"1284366","DOI":"10.3389\/fimmu.2023.1284366","volume":"14","author":"SL Ali","year":"2023","unstructured":"Ali SL, Ali A, Alamri A, Baiduissenova A, Dusmagambetov M, Abduldayeva A et al (2023) Genomic annotation for vaccine target identification and immunoinformatics-guided multi-epitope-based vaccine design against Songling virus through screening its whole genome encoded proteins. Front Immunol 14:1284366","journal-title":"Front Immunol"},{"issue":"1","key":"4277_CR6","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12896-024-00873-2","volume":"24","author":"FQJ Al-Zayadi","year":"2024","unstructured":"Al-Zayadi FQJ, Shakir AS, Kareem AS, Ghasemian A, Behmard E (2024) Design of a novel multi-epitope vaccine against Marburg virus using immunoinformatics studies. BMC Biotechnol 24(1):45","journal-title":"BMC Biotechnol"},{"issue":"8","key":"4277_CR7","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1021\/acsinfecdis.9b00091","volume":"5","author":"P Amatya","year":"2019","unstructured":"Amatya P, Wagner N, Chen G, Luthra P, Shi L, Borek D et al (2019) Inhibition of Marburg virus RNA synthesis by a synthetic anti-VP35 antibody. ACS Infect Dis 5(8):1385\u20131396","journal-title":"ACS Infect Dis"},{"issue":"1","key":"4277_CR8","doi-asserted-by":"publisher","first-page":"113","DOI":"10.7589\/2014-08-198","volume":"51","author":"BR Amman","year":"2015","unstructured":"Amman BR, Jones MEB, Sealy TK, Uebelhoer LS, Schuh AJ, Bird BH et al (2015) Oral shedding of Marburg virus in experimentally infected Egyptian fruit bats (Rousettus aegyptiacus). J Wildl Dis 51(1):113\u2013124","journal-title":"J Wildl Dis"},{"issue":"12","key":"4277_CR9","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.3390\/v13122394","volume":"13","author":"BR Amman","year":"2021","unstructured":"Amman BR, Schuh AJ, Albari\u00f1o CG, Towner JS (2021) Marburg virus persistence on fruit as a plausible route of bat to primate filovirus transmission. Viruses 13(12):2394","journal-title":"Viruses"},{"issue":"19","key":"4277_CR10","first-page":"751","volume":"60","author":"VB Andrijich","year":"1981","unstructured":"Andrijich VB (1981) Marburg virus disease. The diagnosis and management of suspected cases. S Afr Med J 60(19):751\u2013753","journal-title":"S Afr Med J"},{"key":"4277_CR11","first-page":"101745","volume":"39","author":"C Aram","year":"2024","unstructured":"Aram C, Alijanizadeh P, Saleki K, Karami L (2024) Development of an ancestral DC and TLR4-inducing multi-epitope peptide vaccine against the spike protein of SARS-CoV and SARS-CoV-2 using the advanced immunoinformatics approaches. Biochem Biophys Rep 39:101745","journal-title":"Biochem Biophys Rep"},{"issue":"3","key":"4277_CR12","first-page":"332","volume":"28","author":"A Asad","year":"2020","unstructured":"Asad A, Aamir A, Qureshi NE, Bhimani S, Jatoi NN, Batra S et al (2020) Past and current advances in Marburg virus disease: a review. Le Infez Med 28(3):332\u2013345","journal-title":"Le Infez Med"},{"issue":"5","key":"4277_CR13","doi-asserted-by":"publisher","first-page":"e280223214111","DOI":"10.2174\/1871526523666230228103845","volume":"23","author":"S Ashique","year":"2023","unstructured":"Ashique S, Chaudhary V, Pal S, Panwar J, Kumar M, Pramanik S et al (2023) Marburg Virus\u2014a threat during SARS-CoV-2 era: a review. Infect Disord Drug Targets 23(5):e280223214111","journal-title":"Infect Disord Drug Targets"},{"issue":"1","key":"4277_CR14","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1186\/s12879-024-10043-6","volume":"24","author":"A Atefi","year":"2024","unstructured":"Atefi A, Ghanaatpisheh A, Ghasemi A, Haghshenas H, Eyvani K, Bakhshi A et al (2024) Meningitis after COVID-19 vaccination, a systematic review of case reports and case series. BMC Infect Dis 24(1):1138. https:\/\/doi.org\/10.1186\/s12879-024-10043-6","journal-title":"BMC Infect Dis"},{"issue":"1","key":"4277_CR15","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1186\/s12879-018-3409-x","volume":"18","author":"P Babirye","year":"2018","unstructured":"Babirye P, Musubika C, Kirimunda S, Downing R, Lutwama JJ, Mbidde EK et al (2018) Identity and validity of conserved B cell epitopes of filovirus glycoprotein: towards rapid diagnostic testing for Ebola and possibly Marburg virus disease. BMC Infect Dis 18(1):498","journal-title":"BMC Infect Dis"},{"issue":"21","key":"4277_CR16","doi-asserted-by":"publisher","first-page":"13421","DOI":"10.1128\/JVI.79.21.13421-13433.2005","volume":"79","author":"S Bamberg","year":"2005","unstructured":"Bamberg S, Kolesnikova L, M\u00f6ller P, Klenk H-D, Becker S (2005) VP24 of Marburg virus influences formation of infectious particles. J Virol 79(21):13421\u201313433","journal-title":"J Virol"},{"key":"4277_CR17","doi-asserted-by":"publisher","first-page":"662218","DOI":"10.3389\/fimmu.2021.662218","volume":"12","author":"S Barman","year":"2021","unstructured":"Barman S, Soni D, Brook B, Nanishi E, Dowling DJ (2021) Precision vaccine development: cues from natural immunity. Front Immunol 12:662218","journal-title":"Front Immunol"},{"issue":"14","key":"4277_CR18","doi-asserted-by":"publisher","first-page":"7945","DOI":"10.1128\/JVI.77.14.7945-7956.2003","volume":"77","author":"CF Basler","year":"2003","unstructured":"Basler CF, Mikulasova A, Martinez-Sobrido L, Paragas J, M\u00fchlberger E, Bray M et al (2003) The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3. J Virol 77(14):7945\u20137956","journal-title":"J Virol"},{"issue":"Pt 4","key":"4277_CR19","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1099\/0022-1317-75-4-809","volume":"75","author":"S Becker","year":"1994","unstructured":"Becker S, Huppertz S, Klenk HD, Feldmann H (1994) The nucleoprotein of Marburg virus is phosphorylated. J Gen Virol 75(Pt 4):809\u2013818","journal-title":"J Gen Virol"},{"key":"4277_CR20","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/1742-4690-10-123","volume":"10","author":"N Ben Haij","year":"2013","unstructured":"Ben Haij N, Leghmari K, Plan\u00e8s R, Thieblemont N, Bahraoui E (2013) HIV-1 Tat protein binds to TLR4-MD2 and signals to induce TNF-\u03b1 and IL-10. Retrovirology 10:123","journal-title":"Retrovirology"},{"issue":"2","key":"4277_CR21","doi-asserted-by":"publisher","first-page":"131","DOI":"10.4149\/av_2020_203","volume":"64","author":"K Be\u0148ov\u00e1","year":"2020","unstructured":"Be\u0148ov\u00e1 K, Hanckov\u00e1 M, Ko\u010di K, K\u00fadelov\u00e1 M, Bet\u00e1kov\u00e1 T (2020) T cells and their function in the immune response to viruses. Acta Virol 64(2):131\u2013143","journal-title":"Acta Virol"},{"issue":"11","key":"4277_CR22","doi-asserted-by":"publisher","first-page":"e1001196","DOI":"10.1371\/journal.pbio.1001196","volume":"9","author":"TAM Bharat","year":"2011","unstructured":"Bharat TAM, Riches JD, Kolesnikova L, Welsch S, Kr\u00e4hling V, Davey N et al (2011) Cryo-electron tomography of Marburg virus particles and their morphogenesis within infected cells. PLoS Biol 9(11):e1001196","journal-title":"PLoS Biol"},{"issue":"1","key":"4277_CR23","doi-asserted-by":"publisher","first-page":"2149351","DOI":"10.1080\/22221751.2022.2149351","volume":"12","author":"J Bi","year":"2023","unstructured":"Bi J, Wang H, Han Q, Pei H, Wang H, Jin H et al (2023) A rabies virus-vectored vaccine expressing two copies of the Marburg virus glycoprotein gene induced neutralizing antibodies against Marburg virus in humanized mice. Emerg Microbes Infect 12(1):2149351","journal-title":"Emerg Microbes Infect"},{"issue":"11","key":"4277_CR24","doi-asserted-by":"publisher","first-page":"658","DOI":"10.3390\/v10110658","volume":"10","author":"PW Blair","year":"2018","unstructured":"Blair PW, Keshtkar-Jahromi M, Psoter KJ, Reisler RB, Warren TK, Johnston SC et al (2018) Virulence of Marburg virus Angola compared to Mt. Elgon (Musoke) in Macaques: a pooled survival analysis. Viruses 10(11):658","journal-title":"Viruses"},{"issue":"5","key":"4277_CR25","doi-asserted-by":"publisher","first-page":"543","DOI":"10.3390\/vaccines12050543","volume":"12","author":"SR Bonam","year":"2024","unstructured":"Bonam SR, Hazell NC, Mathew MJ, Liang Y, Zhang X, Wei Z et al (2024) Innate and adaptive immune parameters following mRNA vaccination in mice. Vaccines 12(5):543","journal-title":"Vaccines"},{"key":"4277_CR26","doi-asserted-by":"publisher","first-page":"31142","DOI":"10.1073\/pnas.1922654117","volume":"117","author":"NG Bozhanova","year":"2020","unstructured":"Bozhanova NG, Sangha AK, Sevy AM, Gilchuk P, Huang K, Nargi RS et al (2020) Discovery of Marburg virus neutralizing antibodies from virus-na\u00efve human antibody repertoires using large-scale structural predictions. Proc Natl Acad Sci 117:31142\u201331148","journal-title":"Proc Natl Acad Sci"},{"key":"4277_CR27","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-4087897\/v1","author":"A Bukreyev","year":"2024","unstructured":"Bukreyev A, Meyer M, Gunn B, Pietzsch C, Subramani C, Saphire E et al (2024) Divergent antibody recognition profiles are generated by protective mRNA vaccines against Marburg and Ravn viruses. Res Sq. https:\/\/doi.org\/10.21203\/rs.3.rs-4087897\/v1","journal-title":"Res Sq"},{"issue":"1","key":"4277_CR28","doi-asserted-by":"publisher","first-page":"25331","DOI":"10.1038\/s41598-024-76798-9","volume":"14","author":"Z Cao","year":"2024","unstructured":"Cao Z, Zhu J, Wang Z, Peng Y, Zeng L (2024) Comprehensive pan-cancer analysis reveals ENC1 as a promising prognostic biomarker for tumor microenvironment and therapeutic responses. Sci Rep 14(1):25331","journal-title":"Sci Rep"},{"issue":"11","key":"4277_CR29","doi-asserted-by":"publisher","first-page":"5168","DOI":"10.1128\/JVI.02199-05","volume":"80","author":"WB C\u00e1rdenas","year":"2006","unstructured":"C\u00e1rdenas WB, Loo Y-M, Gale MJ, Hartman AL, Kimberlin CR, Mart\u00ednez-Sobrido L et al (2006) Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha\/beta interferon production induced by RIG-I signaling. J Virol 80(11):5168\u20135178","journal-title":"J Virol"},{"issue":"7364","key":"4277_CR30","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/nature10348","volume":"477","author":"JE Carette","year":"2011","unstructured":"Carette JE, Raaben M, Wong AC, Herbert AS, Obernosterer G, Mulherkar N et al (2011) Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Nature 477(7364):340\u2013343. https:\/\/doi.org\/10.1038\/nature10348","journal-title":"Nature"},{"issue":"11","key":"4277_CR31","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/s41573-021-00283-5","volume":"20","author":"N Chaudhary","year":"2021","unstructured":"Chaudhary N, Weissman D, Whitehead KA (2021) mRNA vaccines for infectious diseases: principles, delivery and clinical translation. Nat Rev Drug Discov 20(11):817\u2013838. https:\/\/doi.org\/10.1038\/s41573-021-00283-5","journal-title":"Nat Rev Drug Discov"},{"key":"4277_CR32","doi-asserted-by":"publisher","first-page":"1166022","DOI":"10.3389\/fphar.2023.1166022","volume":"14","author":"F Chen","year":"2023","unstructured":"Chen F, Wang Y, Wang K, Chen J, Jin K, Peng K et al (2023a) Effects of Litsea cubeba essential oil on growth performance, blood antioxidation, immune function, apparent digestibility of nutrients, and fecal microflora of pigs. Front Pharmacol 14:1166022","journal-title":"Front Pharmacol"},{"key":"4277_CR33","doi-asserted-by":"publisher","first-page":"114839","DOI":"10.1016\/j.biopha.2023.114839","volume":"163","author":"L Chen","year":"2023","unstructured":"Chen L, He Y, Zhu J, Zhao S, Qi S, Chen X et al (2023b) The roles and mechanism of m6A RNA methylation regulators in cancer immunity. Biomed Pharmacother 163:114839","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"4277_CR34","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.3390\/biom11081072","volume":"11","author":"R Cid","year":"2021","unstructured":"Cid R, Bol\u00edvar J (2021) Platforms for production of protein-based vaccines: from classical to next-generation strategies. Biomolecules 11(8):1072","journal-title":"Biomolecules"},{"issue":"9","key":"4277_CR35","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.3390\/vaccines10091446","volume":"10","author":"B-AG Coller","year":"2022","unstructured":"Coller B-AG, Lapps WJ, Yunus M, Bruno S, Eichberg MJ, Lee AW-T et al (2022) Lessons learned from the development and roll-out of the rVSV\u0394G-ZEBOV-GP Zaire ebolavirus vaccine to inform Marburg virus and Sudan ebolavirus vaccines. Vaccines 10(9):1446","journal-title":"Vaccines"},{"issue":"7364","key":"4277_CR36","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nature10380","volume":"477","author":"M C\u00f4t\u00e9","year":"2011","unstructured":"C\u00f4t\u00e9 M, Misasi J, Ren T, Bruchez A, Lee K, Filone CM et al (2011) Small molecule inhibitors reveal Niemann\u2013Pick C1 is essential for Ebola virus infection. Nature 477(7364):344\u2013348. https:\/\/doi.org\/10.1038\/nature10380","journal-title":"Nature"},{"issue":"5","key":"4277_CR37","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1016\/j.ymthe.2022.01.034","volume":"30","author":"L Coughlan","year":"2022","unstructured":"Coughlan L, Kremer EJ, Shayakhmetov DM (2022) Adenovirus-based vaccines\u2014a platform for pandemic preparedness against emerging viral pathogens. Mol Ther 30(5):1822\u20131849. https:\/\/doi.org\/10.1016\/j.ymthe.2022.01.034","journal-title":"Mol Ther"},{"issue":"Suppl 2","key":"4277_CR39","doi-asserted-by":"publisher","first-page":"S258","DOI":"10.1093\/infdis\/jiv182","volume":"212","author":"RW Cross","year":"2015","unstructured":"Cross RW, Fenton KA, Geisbert JB, Ebihara H, Mire CE, Geisbert TW (2015) Comparison of the pathogenesis of the Angola and Ravn strains of Marburg virus in the outbred guinea pig model. J Infect Dis 212(Suppl 2):S258\u2013S270","journal-title":"J Infect Dis"},{"issue":"10","key":"4277_CR38","doi-asserted-by":"publisher","first-page":"e1010805","DOI":"10.1371\/journal.ppat.1010805","volume":"18","author":"RW Cross","year":"2022","unstructured":"Cross RW, Longini IM, Becker S, Bok K, Boucher D, Carroll MW et al (2022) An introduction to the Marburg virus vaccine consortium, MARVAC. PLoS Pathog 18(10):e1010805","journal-title":"PLoS Pathog"},{"issue":"19","key":"4277_CR122","doi-asserted-by":"publisher","first-page":"9659","DOI":"10.1128\/jvi.00959-06","volume":"80","author":"KM Daddario-DiCaprio","year":"2006","unstructured":"Daddario-DiCaprio KM, Geisbert TW, Geisbert JB, Str\u00f6her U, Hensley L, Grolla A et al (2006) Cross-protection against Marburg virus strains by using a live, attenuated recombinant vaccine. J Virol 80(19):9659\u20139666. https:\/\/doi.org\/10.1128\/jvi.00959-06","journal-title":"J Virol"},{"issue":"1","key":"4277_CR40","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s43141-023-00575-w","volume":"21","author":"B Debroy","year":"2023","unstructured":"Debroy B, Chowdhury S, Pal K (2023) Designing a novel and combinatorial multi-antigenic epitope-based vaccine \u201cMarVax\u201d against Marburg virus-a reverse vaccinology and immunoinformatics approach. J Genet Eng Biotechnol 21(1):143","journal-title":"J Genet Eng Biotechnol"},{"issue":"4","key":"4277_CR41","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s12026-023-09374-4","volume":"71","author":"J Dey","year":"2023","unstructured":"Dey J, Mahapatra SR, Singh PK, Prabhuswamimath SC, Misra N, Suar M (2023) Designing of multi-epitope peptide vaccine against Acinetobacter baumannii through combined immunoinformatics and protein interaction-based approaches. Immunol Res 71(4):639\u2013662","journal-title":"Immunol Res"},{"issue":"2","key":"4277_CR42","doi-asserted-by":"publisher","first-page":"101751","DOI":"10.1016\/j.jksus.2021.101751","volume":"34","author":"A Dhasmana","year":"2022","unstructured":"Dhasmana A, Dhasmana S, Alsulimani A, Kotnala S, Kashyap VK, Haque S et al (2022) In silico CD4 + T-cell multiepitope prediction and HLA distribution analysis for Marburg virus\u2014a strategy for vaccine designing. J King Saud Univ Sci 34(2):101751","journal-title":"J King Saud Univ Sci"},{"issue":"15","key":"4277_CR43","doi-asserted-by":"publisher","first-page":"7847","DOI":"10.1128\/JVI.00476-10","volume":"84","author":"O Dolnik","year":"2010","unstructured":"Dolnik O, Kolesnikova L, Stevermann L, Becker S (2010) Tsg101 is recruited by a late domain of the nucleocapsid protein to support budding of Marburg virus-like particles. J Virol 84(15):7847\u20137856","journal-title":"J Virol"},{"issue":"10","key":"4277_CR44","doi-asserted-by":"publisher","first-page":"e1004463","DOI":"10.1371\/journal.ppat.1004463","volume":"10","author":"O Dolnik","year":"2014","unstructured":"Dolnik O, Kolesnikova L, Welsch S, Strecker T, Schudt G, Becker S (2014) Interaction with Tsg101 is necessary for the efficient transport and release of nucleocapsids in marburg virus-infected cells. PLoS Pathog 10(10):e1004463","journal-title":"PLoS Pathog"},{"issue":"7\u20139","key":"4277_CR45","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.ejcb.2015.05.006","volume":"94","author":"O Dolnik","year":"2015","unstructured":"Dolnik O, Stevermann L, Kolesnikova L, Becker S (2015) Marburg virus inclusions: a virus-induced microcompartment and interface to multivesicular bodies and the late endosomal compartment. Eur J Cell Biol 94(7\u20139):323\u2013331","journal-title":"Eur J Cell Biol"},{"key":"4277_CR46","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.cca.2020.04.002","volume":"507","author":"J Duan","year":"2020","unstructured":"Duan J, Zhao Y, Zhang X, Jiang H, Xie B, Zhao T et al (2020) Research status and perspectives for pathogenic spirochete vaccines. Clin Chim Acta 507:117\u2013124","journal-title":"Clin Chim Acta"},{"issue":"4","key":"4277_CR47","doi-asserted-by":"publisher","first-page":"e14489","DOI":"10.1111\/cns.14489","volume":"30","author":"W-W Duan","year":"2024","unstructured":"Duan W-W, Yang L-T, Liu J, Dai Z-Y, Wang Z-Y, Zhang H et al (2024a) A TGF-\u03b2 signaling-related lncRNA signature for prediction of glioma prognosis, immune microenvironment, and immunotherapy response. CNS Neurosci Ther 30(4):e14489","journal-title":"CNS Neurosci Ther"},{"issue":"6","key":"4277_CR48","doi-asserted-by":"publisher","first-page":"4950","DOI":"10.1021\/acs.jmedchem.4c00090","volume":"67","author":"J-L Duan","year":"2024","unstructured":"Duan J-L, Wang C-C, Yuan Y, Hui Z, Zhang H, Mao N-D et al (2024b) Design, synthesis, and structure\u2013activity relationship of novel pyridazinone-based PARP7\/HDACs dual inhibitors for elucidating the relationship between antitumor immunity and HDACs inhibition. J Med Chem 67(6):4950\u20134976. https:\/\/doi.org\/10.1021\/acs.jmedchem.4c00090","journal-title":"J Med Chem"},{"key":"4277_CR49","doi-asserted-by":"publisher","first-page":"54483","DOI":"10.12775\/QS.2024.22.54483","volume":"22","author":"M Dydyk","year":"2024","unstructured":"Dydyk M, Nowak A (2024) Experimental success in Marburg virus vaccination. Qual Sport 22:54483","journal-title":"Qual Sport"},{"issue":"6","key":"4277_CR50","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/j.celrep.2014.01.043","volume":"6","author":"MR Edwards","year":"2014","unstructured":"Edwards MR, Johnson B, Mire CE, Xu W, Shabman RS, Speller LN et al (2014) The Marburg virus VP24 protein interacts with Keap1 to activate the cytoprotective antioxidant response pathway. Cell Rep 6(6):1017\u20131025","journal-title":"Cell Rep"},{"issue":"5","key":"4277_CR51","doi-asserted-by":"publisher","first-page":"e0224322","DOI":"10.1128\/mbio.02243-22","volume":"13","author":"MR Edwards","year":"2022","unstructured":"Edwards MR, Vogel OA, Mori H, Davey RA, Basler CF (2022) Marburg virus VP30 is required for transcription initiation at the glycoprotein gene. Mbio 13(5):e0224322","journal-title":"Mbio"},{"key":"4277_CR52","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1128\/JVI.80.2.1038-1043.2006","volume":"80","author":"S Enterlein","year":"2006","unstructured":"Enterlein S, Volchkov VE, Weik M, Kolesnikova L, Volchkova VA, Klenk HD et al (2006) Rescue of recombinant Marburg virus from cDNA is dependent on nucleocapsid protein VP30. J Virol 80:1038\u20131043","journal-title":"J Virol"},{"issue":"1","key":"4277_CR53","doi-asserted-by":"publisher","first-page":"19707","DOI":"10.1038\/s41598-021-99227-7","volume":"11","author":"AO Fadaka","year":"2021","unstructured":"Fadaka AO, Sibuyi NRS, Martin DR, Goboza M, Klein A, Madiehe AM et al (2021) Immunoinformatics design of a novel epitope-based vaccine candidate against dengue virus. Sci Rep 11(1):19707","journal-title":"Sci Rep"},{"issue":"24","key":"4277_CR55","doi-asserted-by":"publisher","first-page":"14440","DOI":"10.1128\/JVI.02069-14","volume":"88","author":"AR Feagins","year":"2014","unstructured":"Feagins AR, Basler CF (2014) The VP40 protein of Marburg virus exhibits impaired budding and increased sensitivity to human tetherin following mouse adaptation. J Virol 88(24):14440\u201314450","journal-title":"J Virol"},{"issue":"Suppl 2","key":"4277_CR54","doi-asserted-by":"publisher","first-page":"S219","DOI":"10.1093\/infdis\/jiv010","volume":"212","author":"AR Feagins","year":"2015","unstructured":"Feagins AR, Basler CF (2015) Amino acid residue at position 79 of Marburg virus VP40 confers interferon antagonism in mouse cells. J Infect Dis 212(Suppl 2):S219\u2013S225","journal-title":"J Infect Dis"},{"issue":"1","key":"4277_CR56","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/0042-6822(91)90680-A","volume":"182","author":"H Feldmann","year":"1991","unstructured":"Feldmann H, Will C, Schikore M, Slenczka W, Klenk HD (1991) Glycosylation and oligomerization of the spike protein of Marburg virus. Virology 182(1):353\u2013356","journal-title":"Virology"},{"issue":"1","key":"4277_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0168-1702(92)90027-7","volume":"24","author":"H Feldmann","year":"1992","unstructured":"Feldmann H, M\u00fchlberger E, Randolf A, Will C, Kiley MP, Sanchez A et al (1992) Marburg virus, a filovirus: messenger RNAs, gene order, and regulatory elements of the replication cycle. Virus Res 24(1):1\u201319","journal-title":"Virus Res"},{"key":"4277_CR58","first-page":"159","volume":"15","author":"H Feldmann","year":"1999","unstructured":"Feldmann H, Volchkov VE, Volchkova VA, Klenk HD (1999) The glycoproteins of Marburg and Ebola virus and their potential roles in pathogenesis. Arch Virol Suppl 15:159\u2013169","journal-title":"Arch Virol Suppl"},{"key":"4277_CR59","doi-asserted-by":"crossref","unstructured":"Fierro C, Sanchez-Crespo N, Makrinos D, Zhang W, Sun Y, Rohilla P et al (2024) Shared clinical and immunologic features of mRNA vaccines: preliminary results from a comparative clinical study. In: medRxiv","DOI":"10.1101\/2024.11.26.24318005"},{"key":"4277_CR60","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.3390\/vaccines10111935","volume":"10","author":"CL Finch","year":"2022","unstructured":"Finch CL, King TH, Alfson KJ, Albanese KA, Smith JNP, Smock P et al (2022) Single-shot ChAd3-MARV vaccine in modified formulation buffer shows 100\\% protection of NHPs. Vaccines 10:1935","journal-title":"Vaccines"},{"key":"4277_CR61","doi-asserted-by":"publisher","first-page":"e1005212","DOI":"10.1371\/journal.ppat.1005212","volume":"11","author":"ML Fusco","year":"2015","unstructured":"Fusco ML, Hashiguchi T, Cassan R, Biggins JE, Murin CD, Warfield KL et al (2015) Correction: Protective mAbs and cross-reactive mAbs Raised by immunization with engineered Marburg virus GPs. PLoS Pathog 11:e1005212","journal-title":"PLoS Pathog"},{"issue":"suppl_3","key":"4277_CR64","doi-asserted-by":"publisher","first-page":"S1075","DOI":"10.1093\/infdis\/jir349","volume":"204","author":"TW Geisbert","year":"2011","unstructured":"Geisbert TW, Feldmann H (2011) Recombinant vesicular stomatitis virus\u2013based vaccines against Ebola and Marburg virus infections. J Infect Dis 204(suppl_3):S1075\u2013S1081. https:\/\/doi.org\/10.1093\/infdis\/jir349","journal-title":"J Infect Dis"},{"issue":"19","key":"4277_CR62","doi-asserted-by":"publisher","first-page":"10386","DOI":"10.1128\/JVI.00594-10","volume":"84","author":"TW Geisbert","year":"2010","unstructured":"Geisbert TW, Bailey M, Geisbert JB, Asiedu C, Roederer M, Grazia-Pau M et al (2010) Vector choice determines immunogenicity and potency of genetic vaccines against Angola Marburg virus in nonhuman primates. J Virol 84(19):10386\u201310394","journal-title":"J Virol"},{"issue":"9","key":"4277_CR63","doi-asserted-by":"publisher","first-page":"4222","DOI":"10.1128\/JVI.02407-10","volume":"85","author":"TW Geisbert","year":"2011","unstructured":"Geisbert TW, Bailey M, Hensley L, Asiedu C, Geisbert J, Stanley D et al (2011) Recombinant adenovirus serotype 26 (Ad26) and Ad35 vaccine vectors bypass immunity to Ad5 and protect nonhuman primates against ebolavirus challenge. J Virol 85(9):4222\u20134233","journal-title":"J Virol"},{"key":"4277_CR65","doi-asserted-by":"publisher","first-page":"706757","DOI":"10.3389\/fimmu.2021.706757","volume":"12","author":"P Gilchuk","year":"2021","unstructured":"Gilchuk P, Guthals A, Bonissone SR, Shaw JB, Ilinykh PA, Huang K et al (2021) Proteo-genomic analysis identifies two major sites of vulnerability on Ebolavirus glycoprotein for neutralizing antibodies in convalescent human plasma. Front Immunol 12:706757","journal-title":"Front Immunol"},{"issue":"1","key":"4277_CR66","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.virol.2011.11.031","volume":"424","author":"K Gnirss","year":"2012","unstructured":"Gnirss K, K\u00fchl A, Karsten C, Glowacka I, Bertram S, Kaup F et al (2012) Cathepsins B and L activate Ebola but not Marburg virus glycoproteins for efficient entry into cell lines and macrophages independent of TMPRSS2 expression. Virology 424(1):3\u201310","journal-title":"Virology"},{"issue":"3","key":"4277_CR67","doi-asserted-by":"publisher","first-page":"2700","DOI":"10.3390\/ijms24032700","volume":"24","author":"V Gote","year":"2023","unstructured":"Gote V, Bolla PK, Kommineni N, Butreddy A, Nukala PK, Palakurthi SS et al (2023) A comprehensive review of mRNA vaccines. Int J Mol Sci 24(3):2700","journal-title":"Int J Mol Sci"},{"issue":"3","key":"4277_CR68","first-page":"205","volume":"98","author":"A Grolla","year":"2005","unstructured":"Grolla A, Lucht A, Dick D, Strong JE, Feldmann H (2005) Laboratory diagnosis of Ebola and Marburg hemorrhagic fever. Bull Soc Pathol Exot 98(3):205\u2013209","journal-title":"Bull Soc Pathol Exot"},{"key":"4277_CR69","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0580-9517(10)37003-6","volume-title":"Immunology of infection (Methods in microbiology; vol 37)","author":"ASD Groot","year":"2010","unstructured":"Groot ASD, Cohen T, Ardito M, Moise L, Martin B, Berzofsky JA (2010) 3 - Use of Bioinformatics to Predict MHC Ligands and T-cell epitopes: application to epitope-driven vaccine design. In: Kabelitz D, Kaufmann SHE (eds) Immunology of infection (Methods in microbiology; vol 37). Academic Press, London, pp 35\u201366"},{"key":"4277_CR70","doi-asserted-by":"publisher","first-page":"1123805","DOI":"10.3389\/fimmu.2023.1123805","volume":"14","author":"R Gupta","year":"2023","unstructured":"Gupta R, Arora K, Roy SS, Joseph A, Rastogi R, Arora NM et al (2023) Platforms, advances, and technical challenges in virus-like particles-based vaccines. Front Immunol 14:1123805","journal-title":"Front Immunol"},{"key":"4277_CR71","doi-asserted-by":"publisher","first-page":"E9153","DOI":"10.1073\/pnas.1810002115","volume":"115","author":"OAW Haabeth","year":"2018","unstructured":"Haabeth OAW, Blake TR, McKinlay CJ, Waymouth RM, Wender PA, Levy R (2018) mRNA vaccination with charge-altering releasable transporters elicits human T cell responses and cures established tumors in mice. Proc Natl Acad Sci 115:E9153\u2013E9161","journal-title":"Proc Natl Acad Sci"},{"issue":"662","key":"4277_CR72","doi-asserted-by":"publisher","first-page":"eabq1945","DOI":"10.1126\/scitranslmed.abq1945","volume":"14","author":"RL Hajnik","year":"2022","unstructured":"Hajnik RL, Plante JA, Liang Y, Alameh M-G, Tang J, Bonam SR et al (2022) Dual spike and nucleocapsid mRNA vaccination confer protection against SARS-CoV-2 Omicron and Delta variants in preclinical models. Sci Transl Med. 14(662):eabq1945","journal-title":"Sci Transl Med."},{"issue":"10373","key":"4277_CR73","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/S0140-6736(22)02400-X","volume":"401","author":"MJ Hamer","year":"2023","unstructured":"Hamer MJ, Houser KV, Hofstetter AR, Ortega-Villa AM, Lee C, Preston A et al (2023) Safety, tolerability, and immunogenicity of the chimpanzee adenovirus type 3-vectored Marburg virus (cAd3-Marburg) vaccine in healthy adults in the USA: a first-in-human, phase 1, open-label, dose-escalation trial. Lancet (London, England) 401(10373):294\u2013302","journal-title":"Lancet (London, England)"},{"issue":"5","key":"4277_CR74","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.cell.2015.01.041","volume":"160","author":"T Hashiguchi","year":"2015","unstructured":"Hashiguchi T, Fusco ML, Bornholdt ZA, Lee JE, Flyak AI, Matsuoka R et al (2015) Structural basis for Marburg virus neutralization by a cross-reactive human antibody. Cell 160(5):904\u2013912","journal-title":"Cell"},{"key":"4277_CR75","doi-asserted-by":"publisher","first-page":"119701","DOI":"10.1016\/j.ijpharm.2020.119701","volume":"587","author":"TK Henna","year":"2020","unstructured":"Henna TK, Raphey VR, Sankar R, Ameena Shirin VK, Gangadharappa HV, Pramod K (2020) Carbon nanostructures: the drug and the delivery system for brain disorders. Int J Pharm 587:119701","journal-title":"Int J Pharm"},{"issue":"9","key":"4277_CR76","doi-asserted-by":"publisher","first-page":"4952","DOI":"10.1128\/JVI.03361-12","volume":"87","author":"AS Herbert","year":"2013","unstructured":"Herbert AS, Kuehne AI, Barth JF, Ortiz RA, Nichols DK, Zak SE et al (2013) Venezuelan equine encephalitis virus replicon particle vaccine protects nonhuman primates from intramuscular and aerosol challenge with ebolavirus. J Virol 87(9):4952\u20134964","journal-title":"J Virol"},{"issue":"1","key":"4277_CR77","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1006\/viro.1998.9367","volume":"251","author":"M Hevey","year":"1998","unstructured":"Hevey M, Negley DL, Pushko P, Smith JF, Schmaljohn AL (1998) Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates. Virology 251(1):28\u201337","journal-title":"Virology"},{"issue":"12","key":"4277_CR78","doi-asserted-by":"publisher","first-page":"3336","DOI":"10.3390\/v4123336","volume":"4","author":"H Hofmann-Winkler","year":"2012","unstructured":"Hofmann-Winkler H, Kaup F, P\u00f6hlmann S (2012) Host cell factors in filovirus entry: novel players, new insights. Viruses 4(12):3336\u20133362","journal-title":"Viruses"},{"key":"4277_CR79","doi-asserted-by":"publisher","first-page":"107622","DOI":"10.1016\/j.intimp.2021.107622","volume":"97","author":"SA Hosseini","year":"2021","unstructured":"Hosseini SA, Zahedipour F, Mirzaei H, Kazemi OR (2021) Potential SARS-CoV-2 vaccines: concept, progress, and challenges. Int Immunopharmacol 97:107622","journal-title":"Int Immunopharmacol"},{"key":"4277_CR80","doi-asserted-by":"publisher","first-page":"1264612","DOI":"10.3389\/fmicb.2023.1264612","volume":"14","author":"W Hou","year":"2023","unstructured":"Hou W, Wu H, Wang S, Wang W, Wang B, Wang H (2023) Designing a multi-epitope vaccine to control porcine epidemic diarrhea virus infection using immunoinformatics approaches. Front Microbiol 14:1264612","journal-title":"Front Microbiol"},{"issue":"3","key":"4277_CR81","first-page":"178","volume":"72","author":"S Hu","year":"2023","unstructured":"Hu S, Noda T (2023) Filovirus helical nucleocapsid structures. Reprod Syst Sex Disord 72(3):178\u2013190","journal-title":"Reprod Syst Sex Disord"},{"issue":"2","key":"4277_CR82","first-page":"136","volume":"16","author":"L Huang","year":"2021","unstructured":"Huang L, Rong Y, Pan Q, Yi K, Tang X, Zhang Q et al (2021) SARS-CoV-2 vaccine research and development: conventional vaccines and biomimetic nanotechnology strategies. Asian J Pharm Sci 16(2):136\u2013146","journal-title":"Asian J Pharm Sci"},{"issue":"43","key":"4277_CR83","doi-asserted-by":"publisher","first-page":"e40248","DOI":"10.1097\/MD.0000000000040248","volume":"103","author":"H Huang","year":"2024","unstructured":"Huang H, Liao Y, Yu Y, Qin H, Wei YZ, Cao L (2024) Adult-onset neuronal ceroid lipofuscinosis misdiagnosed as autoimmune encephalitis and normal-pressure hydrocephalus: a 10-year case report and case-based review. Medicine (Baltimore) 103(43):e40248","journal-title":"Medicine (Baltimore)"},{"key":"4277_CR84","doi-asserted-by":"crossref","unstructured":"Hunegnaw R, Honko AN, Wang L, Carr D, Murray T, Shi W et al (2021) Rapid and durable protection against Marburg virus with a single-shot ChAd3-MARV GP vaccine. bioRxiv","DOI":"10.1101\/2021.12.22.472410"},{"key":"4277_CR85","doi-asserted-by":"publisher","first-page":"eabq6364","DOI":"10.1126\/scitranslmed.abq6364","volume":"14","author":"R Hunegnaw","year":"2022","unstructured":"Hunegnaw R, Honko AN, Wang L, Carr D, Murray T, Shi W et al (2022) A single-shot ChAd3-MARV vaccine confers rapid and durable protection against Marburg virus in nonhuman primates. Sci Transl Med. 14:eabq6364","journal-title":"Sci Transl Med."},{"issue":"2","key":"4277_CR86","doi-asserted-by":"publisher","first-page":"258","DOI":"10.3390\/v4020258","volume":"4","author":"CL Hunt","year":"2012","unstructured":"Hunt CL, Lennemann NJ, Maury W (2012) Filovirus entry: a novelty in the viral fusion world. Viruses 4(2):258\u2013275","journal-title":"Viruses"},{"issue":"6","key":"4277_CR87","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.chom.2020.03.025","volume":"27","author":"PA Ilinykh","year":"2020","unstructured":"Ilinykh PA, Huang K, Santos RI, Gilchuk P, Gunn BM, Karim MM et al (2020) Non-neutralizing antibodies from a Marburg infection survivor mediate protection by Fc-effector functions and by enhancing efficacy of other antibodies. Cell Host Microbe 27(6):976-991.e11","journal-title":"Cell Host Microbe"},{"key":"4277_CR88","doi-asserted-by":"publisher","first-page":"103528","DOI":"10.1016\/j.transci.2022.103528","volume":"62","author":"JW Jacobs","year":"2023","unstructured":"Jacobs JW, Filkins L, Booth GS, Adkins BD (2023) They come in threes: Marburg virus, emerging infectious diseases, and the blood supply. Transfus Apheres Sci 62:103528","journal-title":"Transfus Apheres Sci"},{"issue":"11","key":"4277_CR89","doi-asserted-by":"publisher","first-page":"8682","DOI":"10.1128\/JVI.72.11.8682-8689.1998","volume":"72","author":"J Jameson","year":"1998","unstructured":"Jameson J, Cruz J, Ennis FA (1998) Human cytotoxic T-lymphocyte repertoire to influenza A viruses. J Virol 72(11):8682\u20138689","journal-title":"J Virol"},{"issue":"5","key":"4277_CR90","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1093\/femsre\/fuv031","volume":"39","author":"S-R Jun","year":"2015","unstructured":"Jun S-R, Leuze MR, Nookaew I, Uberbacher EC, Land M, Zhang Q et al (2015) Ebolavirus comparative genomics. FEMS Microbiol Rev 39(5):764\u2013778. https:\/\/doi.org\/10.1093\/femsre\/fuv031","journal-title":"FEMS Microbiol Rev"},{"issue":"6","key":"4277_CR91","doi-asserted-by":"publisher","first-page":"e01865-18","DOI":"10.1128\/JVI.01865-18","volume":"93","author":"R Keshwara","year":"2019","unstructured":"Keshwara R, Hagen KR, Abreu-Mota T, Papaneri AB, Liu D, Wirblich C et al (2019) A recombinant rabies virus expressing the Marburg virus glycoprotein is dependent upon antibody-mediated cellular cytotoxicity for protection against Marburg virus disease in a murine model. J Virol 93(6):e01865-18","journal-title":"J Virol"},{"key":"4277_CR92","doi-asserted-by":"publisher","first-page":"100076","DOI":"10.1016\/j.soh.2024.100076","volume":"3","author":"RB Khadka","year":"2024","unstructured":"Khadka RB, Karki K, Pandey J, Gyawali R, Chaudhary GP (2024) Strengthening global health resilience: Marburg virus-like particle vaccines and the One Health approach. Sci One Health 3:100076","journal-title":"Sci One Health"},{"issue":"4","key":"4277_CR93","doi-asserted-by":"publisher","first-page":"479","DOI":"10.31557\/apjcb.2024.9.4.479-486","volume":"9","author":"N Khaje","year":"2024","unstructured":"Khaje N, Salehan F, Shakiba D, Shabestari AM, Shoarishoar SS (2024) In vitro assessment of paclitaxel-loaded niosome nanoparticles and their cytotoxic effects on the ovarian cancer cell line A2780CP. Asia Pac J Cancer Biol 9(4):479\u2013486","journal-title":"Asia Pac J Cancer Biol"},{"issue":"1","key":"4277_CR94","doi-asserted-by":"publisher","first-page":"26","DOI":"10.11599\/germs.2013.1034","volume":"3","author":"KH Khan","year":"2013","unstructured":"Khan KH (2013) DNA vaccines: roles against diseases. Germs 3(1):26\u201335","journal-title":"Germs"},{"issue":"1","key":"4277_CR95","doi-asserted-by":"publisher","first-page":"8133","DOI":"10.1038\/s41467-024-51021-5","volume":"15","author":"S Khurana","year":"2024","unstructured":"Khurana S, Grubbs G, Ravichandran S, Cluff E, Kim J, Kuehne AI et al (2024) Longitudinal proteome-wide antibody profiling in Marburg virus survivors identifies wing domain immunogen for vaccine design. Nat Commun 15(1):8133","journal-title":"Nat Commun"},{"issue":"9977","key":"4277_CR96","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1016\/S0140-6736(14)62385-0","volume":"385","author":"H Kibuuka","year":"2015","unstructured":"Kibuuka H, Berkowitz NM, Millard M, Enama ME, Tindikahwa A, Sekiziyivu AB et al (2015) Safety and immunogenicity of Ebola virus and Marburg virus glycoprotein DNA vaccines assessed separately and concomitantly in healthy Ugandan adults: a phase 1b, randomised, double-blind, placebo-controlled clinical trial. Lancet (London, England) 385(9977):1545\u20131554","journal-title":"Lancet (London, England)"},{"issue":"1","key":"4277_CR97","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.chom.2017.12.003","volume":"23","author":"LB King","year":"2018","unstructured":"King LB, Fusco ML, Flyak AI, Bukreyev A, Crowe JE, King LB et al (2018) The Marburgvirus-neutralizing human monoclonal article the marburgvirus-neutralizing human monoclonal antibody MR191 targets a conserved site to block virus receptor binding. Cell Host Microbe 23(1):101-109.e4. https:\/\/doi.org\/10.1016\/j.chom.2017.12.003","journal-title":"Cell Host Microbe"},{"issue":"1","key":"4277_CR98","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.celrep.2015.06.003","volume":"12","author":"RN Kirchdoerfer","year":"2015","unstructured":"Kirchdoerfer RN, Abelson DM, Li S, Wood MR, Saphire EO (2015) Assembly of the Ebola virus nucleoprotein from a chaperoned VP35 complex. Cell Rep 12(1):140\u2013149","journal-title":"Cell Rep"},{"key":"4277_CR99","doi-asserted-by":"publisher","first-page":"e1005937","DOI":"10.1371\/journal.ppat.1005937","volume":"12","author":"RN Kirchdoerfer","year":"2016","unstructured":"Kirchdoerfer RN, Moyer CL, Abelson DM, Saphire EO (2016) The Ebola virus VP30-NP interaction is a regulator of viral RNA synthesis. PLoS Pathog 12:e1005937","journal-title":"PLoS Pathog"},{"issue":"2","key":"4277_CR100","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.virol.2005.10.042","volume":"346","author":"GP Kobinger","year":"2006","unstructured":"Kobinger GP, Feldmann H, Zhi Y, Schumer G, Gao G, Feldmann F et al (2006) Chimpanzee adenovirus vaccine protects against Zaire Ebola virus. Virology 346(2):394\u2013401","journal-title":"Virology"},{"issue":"3","key":"4277_CR101","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1128\/JVI.02670-15","volume":"90","author":"A Koehler","year":"2016","unstructured":"Koehler A, Kolesnikova L, Welzel U, Schudt G, Herwig A, Becker S (2016) A single amino acid change in the marburg virus matrix protein VP40 provides a replicative advantage in a species-specific manner. J Virol 90(3):1444\u20131454","journal-title":"J Virol"},{"issue":"39","key":"4277_CR102","doi-asserted-by":"publisher","first-page":"7665","DOI":"10.1021\/bi300976m","volume":"51","author":"JF Koellhoffer","year":"2012","unstructured":"Koellhoffer JF, Malashkevich VN, Harrison JS, Toro R, Bhosle RC, Chandran K et al (2012) Crystal structure of the Marburg virus GP2 core domain in its postfusion conformation. Biochemistry 51(39):7665\u20137675","journal-title":"Biochemistry"},{"issue":"6136","key":"4277_CR103","doi-asserted-by":"publisher","first-page":"1232910","DOI":"10.1126\/science.1232910","volume":"340","author":"WC Koff","year":"2013","unstructured":"Koff WC, Burton DR, Johnson PR, Walker BD, King CR, Nabel GJ et al (2013) Accelerating next-generation vaccine development for global disease prevention. Science 340(6136):1232910","journal-title":"Science"},{"issue":"8","key":"4277_CR104","doi-asserted-by":"publisher","first-page":"3899","DOI":"10.1128\/JVI.74.8.3899-3904.2000","volume":"74","author":"L Kolesnikova","year":"2000","unstructured":"Kolesnikova L, M\u00fchlberger E, Ryabchikova E, Becker S (2000) Ultrastructural organization of recombinant Marburg virus nucleoprotein: comparison with Marburg virus inclusions. J Virol 74(8):3899\u20133904","journal-title":"J Virol"},{"issue":"22","key":"4277_CR105","doi-asserted-by":"publisher","first-page":"12277","DOI":"10.1128\/JVI.78.22.12277-12287.2004","volume":"78","author":"L Kolesnikova","year":"2004","unstructured":"Kolesnikova L, Bergh\u00f6fer B, Bamberg S, Becker S (2004) Multivesicular bodies as a platform for formation of the Marburg virus envelope. J Virol 78(22):12277\u201312287","journal-title":"J Virol"},{"issue":"4","key":"4277_CR106","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1111\/j.1462-5822.2006.00842.x","volume":"9","author":"L Kolesnikova","year":"2007","unstructured":"Kolesnikova L, Bohil AB, Cheney RE, Becker S (2007a) Budding of Marburgvirus is associated with filopodia. Cell Microbiol 9(4):939\u2013951","journal-title":"Cell Microbiol"},{"issue":"Suppl","key":"4277_CR107","doi-asserted-by":"publisher","first-page":"S232","DOI":"10.1086\/520584","volume":"196","author":"L Kolesnikova","year":"2007","unstructured":"Kolesnikova L, Ryabchikova E, Shestopalov A, Becker S (2007b) Basolateral budding of Marburg virus: VP40 retargets viral glycoprotein GP to the basolateral surface. J Infect Dis 196(Suppl):S232\u2013S236","journal-title":"J Infect Dis"},{"issue":"2","key":"4277_CR108","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1111\/j.1462-5822.2011.01709.x","volume":"14","author":"L Kolesnikova","year":"2012","unstructured":"Kolesnikova L, Mittler E, Schudt G, Shams-Eldin H, Becker S (2012) Phosphorylation of Marburg virus matrix protein VP40 triggers assembly of nucleocapsids with the viral envelope at the plasma membrane. Cell Microbiol 14(2):182\u2013197","journal-title":"Cell Microbiol"},{"issue":"8","key":"4277_CR109","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/JVI.02471-16","volume":"91","author":"IV Kuzmin","year":"2017","unstructured":"Kuzmin IV, Schwarz TM, Ilinykh PA, Jordan I, Ksiazek TG, Sachidanandam R et al (2017) Innate immune responses of bat and human cells to filoviruses: commonalities and distinctions. J Virol 91(8):10\u2013128","journal-title":"J Virol"},{"issue":"1","key":"4277_CR110","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1038\/s41541-021-00390-9","volume":"6","author":"MA Langereis","year":"2021","unstructured":"Langereis MA, Albulescu IC, Stammen-Vogelzangs J, Lambregts M, Stachura K, Miller S et al (2021) An alphavirus replicon-based vaccine expressing a stabilized spike antigen induces protective immunity and prevents transmission of SARS-CoV-2 between cats. NPJ Vaccines 6(1):122","journal-title":"NPJ Vaccines"},{"issue":"2","key":"4277_CR111","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.vaccine.2010.10.037","volume":"29","author":"JE Ledgerwood","year":"2010","unstructured":"Ledgerwood JE, Costner P, Desai N, Holman L, Enama ME, Yamshchikov G et al (2010) A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults. Vaccine 29(2):304\u2013313","journal-title":"Vaccine"},{"issue":"5","key":"4277_CR112","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1097\/INF.0b013e3181d467bc","volume":"29","author":"RJ Leggiadro","year":"2010","unstructured":"Leggiadro RJ (2010) Imported case of Marburg hemorrhagic fever\u2014Colorado, 2008: Centers for Disease Control and Prevention. Pediatr Infect Dis J 29(5):400","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"4277_CR113","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.jmb.2013.11.024","volume":"426","author":"SN Lester","year":"2014","unstructured":"Lester SN, Li K (2014) Toll-like receptors in antiviral innate immunity. J Mol Biol 426(6):1246\u20131264","journal-title":"J Mol Biol"},{"issue":"2","key":"4277_CR114","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/nsmb.1765","volume":"17","author":"DW Leung","year":"2010","unstructured":"Leung DW, Prins KC, Borek DM, Farahbakhsh M, Tufariello JM, Ramanan P et al (2010) Structural basis for dsRNA recognition and interferon antagonism by Ebola VP35. Nat Struct Mol Biol 17(2):165\u2013172","journal-title":"Nat Struct Mol Biol"},{"issue":"3","key":"4277_CR115","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.celrep.2015.03.034","volume":"11","author":"DW Leung","year":"2015","unstructured":"Leung DW, Borek D, Luthra P, Binning JM, Anantpadma M, Liu G et al (2015) An intrinsically disordered peptide from Ebola virus VP35 controls viral RNA synthesis by modulating nucleoprotein\u2013RNA interactions. Cell Rep 11(3):376\u2013389","journal-title":"Cell Rep"},{"issue":"D1","key":"4277_CR116","doi-asserted-by":"publisher","first-page":"D1162","DOI":"10.1093\/nar\/gkae985","volume":"53","author":"Y-Y Li","year":"2025","unstructured":"Li Y-Y, Zhou L-W, Qian F-C, Fang Q-L, Yu Z-M, Cui T et al (2025) scImmOmics: a manually curated resource of single-cell multi-omics immune data. Nucleic Acids Res 53(D1):D1162\u2013D1172","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"4277_CR117","doi-asserted-by":"publisher","first-page":"e70042","DOI":"10.1111\/cns.70042","volume":"30","author":"P-H Lin","year":"2024","unstructured":"Lin P-H, Yao H-Y, Huang L, Fu C-C, Yao X-L, Lian C et al (2024) Autoimmune astrocytopathy double negative for AQP4-IgG and GFAP-IgG: retrospective research of clinical practice, biomarkers, and pathology. CNS Neurosci Ther 30(9):e70042. https:\/\/doi.org\/10.1111\/cns.70042","journal-title":"CNS Neurosci Ther"},{"issue":"1","key":"4277_CR118","first-page":"e2408608","volume":"12","author":"W Lin","year":"2025","unstructured":"Lin W, Shen C, Li M, Ma S, Liu C, Huang J et al (2025) Programmable macrophage vesicle based bionic self-adjuvanting vaccine for immunization against monkeypox virus. Adv Sci (Weinheim, Baden-Wurttemberg, Ger.) 12(1):e2408608","journal-title":"Adv Sci (Weinheim, Baden-Wurttemberg, Ger.)"},{"issue":"Suppl 2","key":"4277_CR119","doi-asserted-by":"publisher","first-page":"S146","DOI":"10.1093\/infdis\/jiv030","volume":"212","author":"N Liu","year":"2015","unstructured":"Liu N, Tao Y, Brenowitz MD, Girvin ME, Lai JR (2015) Structural and functional studies on the Marburg virus GP2 fusion loop. J Infect Dis 212(Suppl 2):S146\u2013S153","journal-title":"J Infect Dis"},{"key":"4277_CR120","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1177\/17407745221110880","volume":"19","author":"IM Longini","year":"2022","unstructured":"Longini IM, Yang Y, Fleming TR, Mu\u00f1oz-Fontela C, Wang R, Ellenberg SS et al (2022) A platform trial design for preventive vaccines against Marburg virus and other emerging infectious disease threats. Clin Trials 19:647\u2013654","journal-title":"Clin Trials"},{"key":"4277_CR121","doi-asserted-by":"publisher","first-page":"155354","DOI":"10.1016\/j.prp.2024.155354","volume":"260","author":"Z Lyu","year":"2024","unstructured":"Lyu Z, Xin M, Oyston DR, Xue T, Kang H, Wang X et al (2024) Cause and consequence of heterogeneity in human mesenchymal stem cells: challenges in clinical application. Pathol Res Pract 260:155354","journal-title":"Pathol Res Pract"},{"issue":"1","key":"4277_CR123","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41541-020-00226-y","volume":"5","author":"DC Malherbe","year":"2020","unstructured":"Malherbe DC, Domi A, Hauser MJ, Meyer M, Gunn BM, Alter G et al (2020) Modified vaccinia Ankara vaccine expressing Marburg virus-like particles protects guinea pigs from lethal Marburg virus infection. NPJ Vaccines 5(1):78","journal-title":"NPJ Vaccines"},{"issue":"1","key":"4277_CR124","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.virol.2006.06.041","volume":"358","author":"B Manicassamy","year":"2007","unstructured":"Manicassamy B, Wang J, Rumschlag E, Tymen S, Volchkova V, Volchkov V et al (2007) Characterization of Marburg virus glycoprotein in viral entry. Virology 358(1):79\u201388","journal-title":"Virology"},{"issue":"11","key":"4277_CR125","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1128\/CVI.00162-06","volume":"13","author":"JE Martin","year":"2006","unstructured":"Martin JE, Sullivan NJ, Enama ME, Gordon IJ, Roederer M, Koup RA et al (2006) A DNA vaccine for Ebola virus is safe and immunogenic in a phase I clinical trial. Clin Vaccine Immunol 13(11):1267\u20131277","journal-title":"Clin Vaccine Immunol"},{"issue":"21","key":"4277_CR126","doi-asserted-by":"publisher","first-page":"12090","DOI":"10.1128\/JVI.78.21.12090-12095.2004","volume":"78","author":"A Marzi","year":"2004","unstructured":"Marzi A, Gramberg T, Simmons G, M\u00f6ller P, Rennekamp AJ, Krumbiegel M et al (2004) DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus. J Virol 78(21):12090\u201312095","journal-title":"J Virol"},{"key":"4277_CR127","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.3389\/fimmu.2018.03071","volume":"9","author":"A Marzi","year":"2019","unstructured":"Marzi A, Menicucci AR, Engelmann F, Callison J, Horne EJ, Feldmann F et al (2019) Protection against Marburg virus using a recombinant VSV-vaccine depends on T and B cell activation. Front Immunol 9:3071. https:\/\/doi.org\/10.3389\/fimmu.2018.03071","journal-title":"Front Immunol"},{"issue":"4","key":"4277_CR128","first-page":"579","volume":"12","author":"A Mbonye","year":"2012","unstructured":"Mbonye A, Wamala J, Kaboyo W, Tugumizemo V, Aceng J, Makumbi I (2012) Repeated outbreaks of viral hemorrhagic fevers in Uganda. Afr Health Sci 12(4):579\u2013583","journal-title":"Afr Health Sci"},{"issue":"9","key":"4277_CR129","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.2217\/fvl.11.79","volume":"6","author":"M Mehedi","year":"2011","unstructured":"Mehedi M, Groseth A, Feldmann H, Ebihara H (2011) Clinical aspects of Marburg hemorrhagic fever. Future Virol 6(9):1091\u20131106","journal-title":"Future Virol"},{"issue":"2","key":"4277_CR130","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.coviro.2012.02.015","volume":"2","author":"EH Miller","year":"2012","unstructured":"Miller EH, Chandran K (2012) Filovirus entry into cells\u2014new insights. Curr Opin Virol 2(2):206\u2013214","journal-title":"Curr Opin Virol"},{"issue":"3","key":"4277_CR131","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pntd.0001567","volume":"6","author":"CE Mire","year":"2012","unstructured":"Mire CE, Miller AD, Carville A, Westmoreland SV, Geisbert JB, Mansfield KG et al (2012) Recombinant vesicular stomatitis virus vaccine vectors expressing filovirus glycoproteins lack neurovirulence in nonhuman primates. PLoS Negl Trop Dis 6(3):1\u201312. https:\/\/doi.org\/10.1371\/journal.pntd.0001567","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"4277_CR132","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.1128\/JVI.06346-11","volume":"86","author":"J Misasi","year":"2012","unstructured":"Misasi J, Chandran K, Yang J-Y, Considine B, Filone CM, C\u00f4t\u00e9 M et al (2012) Filoviruses require endosomal cysteine proteases for entry but exhibit distinct protease preferences. J Virol 86(6):3284\u20133292","journal-title":"J Virol"},{"issue":"1","key":"4277_CR133","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1006\/viro.2001.1027","volume":"287","author":"J Modrof","year":"2001","unstructured":"Modrof J, M\u00f6ritz C, Kolesnikova L, Konakova T, Hartlieb B, Randolf A et al (2001) Phosphorylation of Marburg virus VP30 at serines 40 and 42 is critical for its interaction with NP inclusions. Virology 287(1):171\u2013182","journal-title":"Virology"},{"issue":"7","key":"4277_CR134","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/nri2098","volume":"7","author":"M Mohamadzadeh","year":"2007","unstructured":"Mohamadzadeh M, Chen L, Schmaljohn AL (2007) How Ebola and Marburg viruses battle the immune system. Nat Rev Immunol 7(7):556\u2013567. https:\/\/doi.org\/10.1038\/nri2098","journal-title":"Nat Rev Immunol"},{"key":"4277_CR135","doi-asserted-by":"publisher","first-page":"100009","DOI":"10.1016\/j.jvacx.2019.100009","volume":"1","author":"TP Monath","year":"2019","unstructured":"Monath TP, Fast PE, Modjarrad K, Clarke DK, Martin BK, Fusco J et al (2019) rVSV\u0394G-ZEBOV-GP (also designated V920) recombinant vesicular stomatitis virus pseudotyped with Ebola Zaire glycoprotein: standardized template with key considerations for a risk\/benefit assessment. Vaccine X 1:100009","journal-title":"Vaccine X"},{"issue":"3","key":"4277_CR136","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s12079-022-00697-9","volume":"17","author":"P Morovat","year":"2023","unstructured":"Morovat P, Morovat S, Hosseinpour M, Moslabeh FGZ, Kamali MJ, Samadani AA (2023) Survival-based bioinformatics analysis to identify hub long non-coding RNAs along with lncRNA-miRNA-mRNA network for potential diagnosis\/prognosis of thyroid cancer. J Cell Commun Signal 17(3):639\u2013655. https:\/\/doi.org\/10.1007\/s12079-022-00697-9","journal-title":"J Cell Commun Signal"},{"issue":"2","key":"4277_CR137","doi-asserted-by":"publisher","first-page":"205","DOI":"10.2217\/17460794.2.2.205","volume":"2","author":"E M\u00fchlberger","year":"2007","unstructured":"M\u00fchlberger E (2007) Filovirus replication and transcription. Future Virol 2(2):205\u2013215","journal-title":"Future Virol"},{"issue":"11","key":"4277_CR138","doi-asserted-by":"publisher","first-page":"8756","DOI":"10.1128\/JVI.72.11.8756-8764.1998","volume":"72","author":"E M\u00fchlberger","year":"1998","unstructured":"M\u00fchlberger E, L\u00f6tfering B, Klenk HD, Becker S (1998) Three of the four nucleocapsid proteins of Marburg virus, NP, VP35, and L, are sufficient to mediate replication and transcription of Marburg virus-specific monocistronic minigenomes. J Virol 72(11):8756\u20138764","journal-title":"J Virol"},{"issue":"6","key":"4277_CR139","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1056\/NEJMra1204186","volume":"368","author":"GJ Nabel","year":"2013","unstructured":"Nabel GJ (2013) Designing tomorrow\u2019s vaccines. N Engl J Med 368(6):551\u2013560","journal-title":"N Engl J Med"},{"issue":"9","key":"4277_CR140","doi-asserted-by":"publisher","first-page":"e1001121","DOI":"10.1371\/journal.ppat.1001121","volume":"6","author":"A Nanbo","year":"2010","unstructured":"Nanbo A, Imai M, Watanabe S, Noda T, Takahashi K, Neumann G et al (2010) Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner. PLoS Pathog 6(9):e1001121","journal-title":"PLoS Pathog"},{"key":"4277_CR141","doi-asserted-by":"publisher","first-page":"109265","DOI":"10.1016\/j.intimp.2022.109265","volume":"113","author":"M Negahdaripour","year":"2022","unstructured":"Negahdaripour M, Vakili B, Nezafat N (2022) Exosome-based vaccines and their position in next generation vaccines. Int Immunopharmacol 113:109265","journal-title":"Int Immunopharmacol"},{"key":"4277_CR142","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jtbi.2014.01.018","volume":"349","author":"N Nezafat","year":"2014","unstructured":"Nezafat N, Ghasemi Y, Javadi G, Khoshnoud MJ, Omidinia E (2014) A novel multi-epitope peptide vaccine against cancer: an in silico approach. J Theor Biol 349:121\u2013134","journal-title":"J Theor Biol"},{"key":"4277_CR143","first-page":"104","volume":"3","author":"VV Nikiforov","year":"1994","unstructured":"Nikiforov VV, Turovski\u012d II, Kalinin PP, Akinfeeva LA, Katkova LR, Barmin VS et al (1994) A case of a laboratory infection with Marburg fever. Zhurnal Mikrobiol Epidemiol i Immunobiol 3:104\u2013106","journal-title":"Zhurnal Mikrobiol Epidemiol i Immunobiol"},{"issue":"3","key":"4277_CR144","doi-asserted-by":"publisher","first-page":"e0007257","DOI":"10.1371\/journal.pntd.0007257","volume":"13","author":"L Nyakarahuka","year":"2019","unstructured":"Nyakarahuka L, Shoemaker TR, Balinandi S, Chemos G, Kwesiga B, Mulei S et al (2019) Marburg virus disease outbreak in Kween District Uganda, 2017: epidemiological and laboratory findings. PLoS Negl Trop Dis 13(3):e0007257","journal-title":"PLoS Negl Trop Dis"},{"issue":"15","key":"4277_CR145","doi-asserted-by":"publisher","first-page":"8516","DOI":"10.3390\/ijms25158516","volume":"25","author":"KL O\u2019Donnell","year":"2024","unstructured":"O\u2019Donnell KL, Henderson CW, Anhalt H, Fusco J, Erasmus JH, Lambe T et al (2024) Vaccine platform comparison: protective efficacy against lethal Marburg virus challenge in the Hamster model. Int J Mol Sci 25(15):8516","journal-title":"Int J Mol Sci"},{"issue":"22","key":"4277_CR146","doi-asserted-by":"publisher","first-page":"14189","DOI":"10.1128\/JVI.79.22.14189-14196.2005","volume":"79","author":"GG Olinger","year":"2005","unstructured":"Olinger GG, Bailey MA, Dye JM, Bakken R, Kuehne A, Kondig J et al (2005) Protective cytotoxic T-cell responses induced by Venezuelan equine encephalitis virus replicons expressing Ebola virus proteins. J Virol 79(22):14189\u201314196","journal-title":"J Virol"},{"issue":"9","key":"4277_CR147","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.3390\/vaccines10091516","volume":"10","author":"OV Orlova","year":"2022","unstructured":"Orlova OV, Glazkova DV, Bogoslovskaya EV, Shipulin GA, Yudin SM (2022) Development of modified vaccinia virus Ankara-based vaccines: advantages and applications. Vaccines 10(9):1516","journal-title":"Vaccines"},{"issue":"6","key":"4277_CR148","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.celrep.2014.02.027","volume":"6","author":"A Page","year":"2014","unstructured":"Page A, Volchkova VA, Reid SP, Mateo M, Bagnaud-Baule A, Nemirov K et al (2014) Marburgvirus hijacks nrf2-dependent pathway by targeting nrf2-negative regulator keap1. Cell Rep 6(6):1026\u20131036","journal-title":"Cell Rep"},{"issue":"12","key":"4277_CR149","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1016\/j.vaccine.2017.02.017","volume":"35","author":"S Pagliusi","year":"2017","unstructured":"Pagliusi S, Ting C-C, Lobos F (2017) Vaccines: shaping global health. Vaccine 35(12):1579\u20131585","journal-title":"Vaccine"},{"key":"4277_CR150","doi-asserted-by":"publisher","first-page":"103","DOI":"10.3390\/vaccines11010103","volume":"11","author":"I Papadatou","year":"2023","unstructured":"Papadatou I, Geropeppa M, Verrou K-M, Tzanoudaki M, Lagousi T, Liatsis E et al (2023) SARS-CoV-2 mRNA dual immunization induces innate transcriptional signatures, establishes T-cell memory and coordinates the recall response. Vaccines 11:103","journal-title":"Vaccines"},{"issue":"1","key":"4277_CR151","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s40203-021-00080-3","volume":"9","author":"T Pervin","year":"2021","unstructured":"Pervin T, Oany AR (2021) Vaccinomics approach for scheming potential epitope-based peptide vaccine by targeting l-protein of Marburg virus. Silico Pharmacol 9(1):21","journal-title":"Silico Pharmacol"},{"issue":"1","key":"4277_CR152","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/S0264-410X(00)00113-4","volume":"19","author":"P Pushko","year":"2000","unstructured":"Pushko P, Bray M, Ludwig GV, Parker M, Schmaljohn A, Sanchez A et al (2000) Recombinant RNA replicons derived from attenuated Venezuelan equine encephalitis virus protect guinea pigs and mice from Ebola hemorrhagic fever virus. Vaccine 19(1):142\u2013153","journal-title":"Vaccine"},{"key":"4277_CR153","doi-asserted-by":"publisher","first-page":"633776","DOI":"10.3389\/fcell.2021.633776","volume":"9","author":"F Qin","year":"2021","unstructured":"Qin F, Xia F, Chen H, Cui B, Feng Y, Zhang P et al (2021) A guide to nucleic acid vaccines in the prevention and treatment of infectious diseases and cancers: from basic principles to current applications. Front Cell Dev Biol 9:633776. https:\/\/doi.org\/10.3389\/fcell.2021.633776","journal-title":"Front Cell Dev Biol"},{"issue":"50","key":"4277_CR154","doi-asserted-by":"publisher","first-page":"20661","DOI":"10.1073\/pnas.1213559109","volume":"109","author":"P Ramanan","year":"2012","unstructured":"Ramanan P, Edwards MR, Shabman RS, Leung DW, Endlich-Frazier AC, Borek DM et al (2012) Structural basis for Marburg virus VP35-mediated immune evasion mechanisms. Proc Natl Acad Sci U S A 109(50):20661\u201320666","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4277_CR155","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.virusres.2018.02.003","volume":"247","author":"VK Ramaswamy","year":"2018","unstructured":"Ramaswamy VK, Di Palma F, Vargiu AV, Corona A, Piano D, Ruggerone P et al (2018) Insights into the homo-oligomerization properties of N-terminal coiled-coil domain of Ebola virus VP35 protein. Virus Res 247:61\u201370","journal-title":"Virus Res"},{"key":"4277_CR156","doi-asserted-by":"publisher","first-page":"2662","DOI":"10.3389\/fmicb.2017.02662","volume":"8","author":"S Ren","year":"2017","unstructured":"Ren S, Wei Q, Cai L, Yang X, Xing C, Tan F et al (2017) Alphavirus replicon DNA vectors expressing Ebola GP and VP40 antigens induce humoral and cellular immune responses in mice. Front Microbiol 8:2662","journal-title":"Front Microbiol"},{"issue":"4","key":"4277_CR157","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s11262-017-1455-x","volume":"53","author":"P Reynolds","year":"2017","unstructured":"Reynolds P, Marzi A (2017) Ebola and Marburg virus vaccines. Virus Genes 53(4):501\u2013515","journal-title":"Virus Genes"},{"key":"4277_CR158","doi-asserted-by":"publisher","first-page":"S682","DOI":"10.1093\/infdis\/jiad345","volume":"228","author":"AD Rghei","year":"2023","unstructured":"Rghei AD, Cao W, He S, Lopes JA, Zielinska N, Pei Y et al (2023) AAV-vectored expression of Marburg virus-neutralizing antibody MR191 provides complete protection from challenge in a guinea pig model. J Infect Dis 228:S682\u2013S690","journal-title":"J Infect Dis"},{"key":"4277_CR159","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jcv.2015.01.014","volume":"64","author":"V Rougeron","year":"2015","unstructured":"Rougeron V, Feldmann H, Grard G, Becker S, Leroy EM (2015) Ebola and Marburg haemorrhagic fever. J Clin Virol 64:111\u2013119","journal-title":"J Clin Virol"},{"issue":"9","key":"4277_CR160","doi-asserted-by":"publisher","first-page":"e1001110","DOI":"10.1371\/journal.ppat.1001110","volume":"6","author":"MF Saeed","year":"2010","unstructured":"Saeed MF, Kolokoltsov AA, Albrecht T, Davey RA (2010) Cellular entry of Ebola virus involves uptake by a macropinocytosis-like mechanism and subsequent trafficking through early and late endosomes. PLoS Pathog 6(9):e1001110","journal-title":"PLoS Pathog"},{"issue":"6","key":"4277_CR161","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s12032-024-02339-z","volume":"41","author":"F Saeedi","year":"2024","unstructured":"Saeedi F, Salehi M, Kamali MJ, Mir MA, Kazemi S, Shirafkan F et al (2024) Evaluation of the cytotoxic activities of the essential oil from Pistacia atlantica Desf. oleoresin on human gastric cancer cell lines. Med Oncol 41(6):148. https:\/\/doi.org\/10.1007\/s12032-024-02339-z","journal-title":"Med Oncol"},{"issue":"1","key":"4277_CR162","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1080\/01652176.2022.2116501","volume":"42","author":"R Sah","year":"2022","unstructured":"Sah R, Mohanty A, Reda A, Siddiq A, Mohapatra RK, Dhama K (2022) Marburg virus re-emerged in 2022: recently detected in Ghana, another zoonotic pathogen coming up amid rising cases of Monkeypox and ongoing COVID-19 pandemic\u2014global health concerns and counteracting measures. Vet Q 42(1):167\u2013171","journal-title":"Vet Q"},{"issue":"47","key":"4277_CR163","doi-asserted-by":"publisher","first-page":"32043","DOI":"10.1021\/acsomega.1c04817","volume":"6","author":"SA Sami","year":"2021","unstructured":"Sami SA, Marma KKS, Mahmud S, Khan MAN, Albogami S, El-Shehawi AM et al (2021) Designing of a multi-epitope vaccine against the structural proteins of Marburg virus exploiting the immunoinformatics approach. ACS Omega 6(47):32043\u201332071","journal-title":"ACS Omega"},{"issue":"3","key":"4277_CR164","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1128\/JVI.75.3.1274-1283.2001","volume":"75","author":"C S\u00e4nger","year":"2001","unstructured":"S\u00e4nger C, M\u00fchlberger E, Ryabchikova E, Kolesnikova L, Klenk HD, Becker S (2001) Sorting of Marburg virus surface protein and virus release take place at opposite surfaces of infected polarized epithelial cells. J Virol 75(3):1274\u20131283","journal-title":"J Virol"},{"issue":"3","key":"4277_CR165","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3390\/v14030521","volume":"14","author":"M \u0160antak","year":"2022","unstructured":"\u0160antak M, Mati\u0107 Z (2022) The role of nucleoprotein in immunity to human negative-stranded RNA viruses-not just another brick in the viral nucleocapsid. Viruses 14(3):521","journal-title":"Viruses"},{"issue":"4","key":"4277_CR166","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1093\/infdis\/jiu511","volume":"211","author":"UN Sarwar","year":"2015","unstructured":"Sarwar UN, Costner P, Enama ME, Berkowitz N, Hu Z, Hendel CS et al (2015) Safety and immunogenicity of DNA vaccines encoding Ebolavirus and Marburgvirus wild-type glycoproteins in a phase I clinical trial. J Infect Dis 211(4):549\u2013557","journal-title":"J Infect Dis"},{"issue":"Suppl 3","key":"4277_CR167","doi-asserted-by":"publisher","first-page":"S861","DOI":"10.1093\/infdis\/jir308","volume":"204","author":"KM Schmidt","year":"2011","unstructured":"Schmidt KM, Sch\u00fcmann M, Olejnik J, Kr\u00e4hling V, M\u00fchlberger E (2011) Recombinant Marburg virus expressing EGFP allows rapid screening of virus growth and real-time visualization of virus spread. J Infect Dis 204(Suppl 3):S861\u2013S870","journal-title":"J Infect Dis"},{"issue":"4","key":"4277_CR168","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1172\/JCI116329","volume":"91","author":"HJ Schnittler","year":"1993","unstructured":"Schnittler HJ, Mahner F, Drenckhahn D, Klenk HD, Feldmann H (1993) Replication of Marburg virus in human endothelial cells. A possible mechanism for the development of viral hemorrhagic disease. J Clin Invest 91(4):1301\u20131309","journal-title":"J Clin Invest"},{"issue":"7","key":"4277_CR169","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1038\/mt.2013.61","volume":"21","author":"DJ Shedlock","year":"2013","unstructured":"Shedlock DJ, Aviles J, Talbott KT, Wong G, Wu SJ, Villarreal DO et al (2013) Induction of broad cytotoxic T cells by protective DNA vaccination against Marburg and Ebola. Mol Ther 21(7):1432\u20131444","journal-title":"Mol Ther"},{"issue":"1","key":"4277_CR170","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12985-019-1272-z","volume":"16","author":"K Shifflett","year":"2019","unstructured":"Shifflett K, Marzi A (2019) Marburg virus pathogenesis\u2014differences and similarities in humans and animal models. Virol J 16(1):165","journal-title":"Virol J"},{"issue":"11","key":"4277_CR171","doi-asserted-by":"publisher","first-page":"144","DOI":"10.14715\/cmb\/2024.70.11.21","volume":"70","author":"SS Shoarishoar","year":"2024","unstructured":"Shoarishoar SS, KaboodMehri R, Fakor F, Rafiei-Sorouri Z, Mansour Ghanaei M, Faraji Darkhaneh R et al (2024a) Assessment of decreased ovarian reserve and systemic inflammatory markers. Cell Mol Biol (Noisy-Le-Grand) 70(11):144\u2013149","journal-title":"Cell Mol Biol (Noisy-Le-Grand)"},{"issue":"11","key":"4277_CR172","doi-asserted-by":"publisher","first-page":"109","DOI":"10.14715\/cmb\/2024.70.11.16","volume":"70","author":"SS Shoarishoar","year":"2024","unstructured":"Shoarishoar SS, Milani F, Adineh S, Sorouri ZR, Maryam Attari S (2024b) Comparison of pregnancy outcomes in amniocentesis recipients with normal and abnormal maternal serum analytes. Cell Mol Biol (Noisy-Le-Grand) 70(11):109\u2013114","journal-title":"Cell Mol Biol (Noisy-Le-Grand)"},{"issue":"8","key":"4277_CR175","doi-asserted-by":"publisher","first-page":"e980","DOI":"10.1002\/iid3.980","volume":"11","author":"O Sibomana","year":"2023","unstructured":"Sibomana O, Kubwimana E (2023) First-ever Marburg virus disease outbreak in Equatorial Guinea and Tanzania: an imminent crisis in West and East Africa. Immunity, Inflamm Dis 11(8):e980","journal-title":"Immunity, Inflamm Dis"},{"key":"4277_CR173","doi-asserted-by":"publisher","first-page":"107371","DOI":"10.1016\/j.ijid.2024.107371","volume":"153","author":"O Sibomana","year":"2024","unstructured":"Sibomana O, Hakayuwa CM, Munyantore J (2024) Marburg Virus reaches Rwanda: how close are we to a vaccine solution? Int J Infect Dis 153:107371","journal-title":"Int J Infect Dis"},{"key":"4277_CR174","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2024.107371","author":"O Sibomana","year":"2025","unstructured":"Sibomana O, Hakayuwa CM, Munyantore J (2025) Marburg virus reaches Rwanda: how close are we to a vaccine solution? Int J Infect Dis. https:\/\/doi.org\/10.1016\/j.ijid.2024.107371","journal-title":"Int J Infect Dis"},{"key":"4277_CR176","doi-asserted-by":"publisher","unstructured":"Siegert R (1972) Marburg virus. In: Canine distemper virus: Marburg virus. Springer Vienna, Vienna, pp 97\u2013153. https:\/\/doi.org\/10.1007\/978-3-7091-8302-1_2","DOI":"10.1007\/978-3-7091-8302-1_2"},{"issue":"8276","key":"4277_CR177","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S0140-6736(82)91871-2","volume":"319","author":"DH Smith","year":"1982","unstructured":"Smith DH, Isaacson M, Johnson KM, Bagshawe A, Johnson BK, Swanapoel R et al (1982) Marburg-virus disease in Kenya. Lancet 319(8276):816\u2013820. https:\/\/doi.org\/10.1016\/S0140-6736(82)91871-2","journal-title":"Lancet"},{"issue":"12","key":"4277_CR178","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1586\/erv.10.132","volume":"9","author":"DZ Soghoian","year":"2010","unstructured":"Soghoian DZ, Streeck H (2010) Cytolytic CD4(+) T cells in viral immunity. Expert Rev Vaccines 9(12):1453\u20131463","journal-title":"Expert Rev Vaccines"},{"key":"4277_CR179","doi-asserted-by":"publisher","first-page":"907481","DOI":"10.3389\/fimmu.2022.907481","volume":"13","author":"MA Soltan","year":"2022","unstructured":"Soltan MA, Abdulsahib WK, Amer M, Refaat AM, Bagalagel AA, Diri RM et al (2022) Mining of Marburg virus proteome for designing an epitope-based vaccine. Front Immunol 13:907481","journal-title":"Front Immunol"},{"issue":"11","key":"4277_CR180","doi-asserted-by":"publisher","first-page":"e1661","DOI":"10.1002\/hsr2.1661","volume":"6","author":"D Srivastava","year":"2023","unstructured":"Srivastava D, Kutikuppala LVS, Shanker P, Sahoo RN, Pattnaik G, Dash R et al (2023) The neglected continuously emerging Marburg virus disease in Africa: a global public health threat. Health Sci Rep 6(11):e1661","journal-title":"Health Sci Rep"},{"issue":"10","key":"4277_CR181","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1038\/nm.3702","volume":"20","author":"DA Stanley","year":"2014","unstructured":"Stanley DA, Honko AN, Asiedu C, Trefry JC, Lau-Kilby AW, Johnson JC et al (2014) Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge. Nat Med 20(10):1126\u20131129","journal-title":"Nat Med"},{"issue":"10","key":"4277_CR183","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1080\/21645515.2019.1651140","volume":"15","author":"JJ Suschak","year":"2019","unstructured":"Suschak JJ, Schmaljohn CS (2019) Vaccines against Ebola virus and Marburg virus: recent advances and promising candidates. Hum Vaccin Immunother 15(10):2359\u20132377","journal-title":"Hum Vaccin Immunother"},{"issue":"suppl_5","key":"4277_CR182","first-page":"S519","volume":"218","author":"JJ Suschak","year":"2018","unstructured":"Suschak JJ, Bagley K, Shoemaker CJ, Six C, Kwilas S, Dupuy LC et al (2018) The genetic adjuvants interleukin-12 and granulocyte-macrophage colony stimulating factor enhance the immunogenicity of an Ebola virus deoxyribonucleic acid vaccine in mice. J Infect Dis 218(suppl_5):S519\u2013S527","journal-title":"J Infect Dis"},{"issue":"1","key":"4277_CR184","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12865-023-00585-w","volume":"24","author":"NS Tabibpour","year":"2023","unstructured":"Tabibpour NS, Doosti A, Sharifzadeh A (2023) Putative novel outer membrane antigens multi-epitope DNA vaccine candidates identified by Immunoinformatic approaches to control Acinetobacter baumannii. BMC Immunol 24(1):46","journal-title":"BMC Immunol"},{"issue":"3","key":"4277_CR185","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1080\/07391102.2020.1823884","volume":"40","author":"L Taidi","year":"2022","unstructured":"Taidi L, Maurady A, Britel MR (2022) Molecular docking study and molecular dynamic simulation of human cyclooxygenase-2 (COX-2) with selected eutypoids. J Biomol Struct Dyn 40(3):1189\u20131204","journal-title":"J Biomol Struct Dyn"},{"issue":"14","key":"4277_CR186","doi-asserted-by":"publisher","first-page":"3499","DOI":"10.1158\/1078-0432.CCR-16-2138","volume":"23","author":"M Tanaka","year":"2017","unstructured":"Tanaka M, Tashiro H, Omer B, Lapteva N, Ando J, Ngo M et al (2017) Vaccination targeting native receptors to enhance the function and proliferation of chimeric antigen receptor (CAR)-modified T cells. Clin Cancer Res 23(14):3499\u20133509","journal-title":"Clin Cancer Res"},{"issue":"5","key":"4277_CR187","doi-asserted-by":"publisher","first-page":"779","DOI":"10.3390\/v13050779","volume":"13","author":"M Teng","year":"2021","unstructured":"Teng M, Yao Y, Nair V, Luo J (2021) Latest advances of virology research using CRISPR\/Cas9-based gene-editing technology and its application to vaccine development. Viruses 13(5):779","journal-title":"Viruses"},{"issue":"21","key":"4277_CR188","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/JVI.00426-18","volume":"92","author":"B Tigabu","year":"2018","unstructured":"Tigabu B, Ramanathan P, Ivanov A, Lin X, Ilinykh PA, Parry CS et al (2018) Phosphorylated VP30 of Marburg virus is a repressor of transcription. J Virol 92(21):10\u2013128","journal-title":"J Virol"},{"issue":"3","key":"4277_CR189","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.vaccine.2023.12.053","volume":"42","author":"A To","year":"2024","unstructured":"To A, Wong TAS, Ball AH, Lieberman MM, Yalley-Ogunro J, Cabus M et al (2024) Thermostable bivalent filovirus vaccine protects against severe and lethal Sudan ebolavirus and marburgvirus infection. Vaccine 42(3):598\u2013607. https:\/\/doi.org\/10.1016\/j.vaccine.2023.12.053","journal-title":"Vaccine"},{"issue":"12","key":"4277_CR190","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.3390\/vaccines12121316","volume":"12","author":"A Tscherne","year":"2024","unstructured":"Tscherne A, Kalodimou G, Kupke A, Rohde C, Freudenstein A, Jany S et al (2024) Rapid development of modified vaccinia virus Ankara (MVA)-based vaccine candidates against Marburg virus suitable for clinical use in humans. Vaccines 12(12):1316","journal-title":"Vaccines"},{"issue":"9","key":"4277_CR191","doi-asserted-by":"publisher","first-page":"4309","DOI":"10.1128\/JVI.02575-10","volume":"85","author":"C Valmas","year":"2011","unstructured":"Valmas C, Basler CF (2011) Marburg virus VP40 antagonizes interferon signaling in a species-specific manner. J Virol 85(9):4309\u20134317","journal-title":"J Virol"},{"issue":"1","key":"4277_CR192","doi-asserted-by":"publisher","first-page":"e1000721","DOI":"10.1371\/journal.ppat.1000721","volume":"6","author":"C Valmas","year":"2010","unstructured":"Valmas C, Grosch MN, Sch\u00fcmann M, Olejnik J, Martinez O, Best SM et al (2010) Marburg virus evades interferon responses by a mechanism distinct from Ebola virus. PLoS Pathog 6(1):e1000721","journal-title":"PLoS Pathog"},{"issue":"1","key":"4277_CR193","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1006\/viro.1998.9176","volume":"246","author":"L Vanderzanden","year":"1998","unstructured":"Vanderzanden L, Bray M, Fuller D, Roberts T, Custer D, Spik K et al (1998) DNA vaccines expressing either the GP or NP genes of Ebola virus protect mice from lethal challenge. Virology 246(1):134\u2013144","journal-title":"Virology"},{"key":"4277_CR194","doi-asserted-by":"publisher","first-page":"1043109","DOI":"10.3389\/fimmu.2023.1043109","volume":"14","author":"SK Verma","year":"2023","unstructured":"Verma SK, Mahajan P, Singh NK, Gupta A, Aggarwal R, Rappuoli R et al (2023) New-age vaccine adjuvants, their development, and future perspective. Front Immunol 14:1043109","journal-title":"Front Immunol"},{"issue":"1","key":"4277_CR195","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1006\/viro.1999.0110","volume":"268","author":"VE Volchkov","year":"2000","unstructured":"Volchkov VE, Volchkova VA, Str\u00f6her U, Becker S, Dolnik O, Cieplik M et al (2000) Proteolytic processing of Marburg virus glycoprotein. Virology 268(1):1\u20136","journal-title":"Virology"},{"issue":"4","key":"4277_CR196","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s10517-021-05091-w","volume":"170","author":"NV Volkova","year":"2021","unstructured":"Volkova NV, Pyankov OV, Ivanova AV, Isaeva AA, Zybkina AV, Kazachinskaya EI et al (2021) Prototype of a DNA vaccine against Marburg virus. Bull Exp Biol Med 170(4):475\u2013478. https:\/\/doi.org\/10.1007\/s10517-021-05091-w","journal-title":"Bull Exp Biol Med"},{"issue":"5877","key":"4277_CR197","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1126\/science.1152622","volume":"320","author":"BD Walker","year":"2008","unstructured":"Walker BD, Burton DR (2008) Toward an AIDS vaccine. Science 320(5877):760\u2013764","journal-title":"Science"},{"issue":"7680","key":"4277_CR198","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/nature24490","volume":"551","author":"W Wan","year":"2017","unstructured":"Wan W, Kolesnikova L, Clarke M, Koehler A, Noda T, Becker S et al (2017) Structure and assembly of the Ebola virus nucleocapsid. Nature 551(7680):394\u2013397","journal-title":"Nature"},{"key":"4277_CR199","doi-asserted-by":"publisher","first-page":"115340","DOI":"10.1016\/j.addr.2024.115340","volume":"210","author":"C Wang","year":"2024","unstructured":"Wang C, Yuan F (2024) A comprehensive comparison of DNA and RNA vaccines. Adv Drug Deliv Rev 210:115340","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"4277_CR200","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.virol.2006.05.033","volume":"353","author":"D Wang","year":"2006","unstructured":"Wang D, Hevey M, Juompan LY, Trubey CM, Raja NU, Deitz SB et al (2006) Complex adenovirus-vectored vaccine protects guinea pigs from three strains of Marburg virus challenges. Virology 353(2):324\u2013332","journal-title":"Virology"},{"issue":"suppl_3","key":"4277_CR201","doi-asserted-by":"publisher","first-page":"S1053","DOI":"10.1093\/infdis\/jir346","volume":"204","author":"KL Warfield","year":"2011","unstructured":"Warfield KL, Aman MJ (2011) Advances in virus-like particle vaccines for filoviruses. J Infect Dis 204(suppl_3):S1053\u2013S1059. https:\/\/doi.org\/10.1093\/infdis\/jir346","journal-title":"J Infect Dis"},{"issue":"17","key":"4277_CR202","doi-asserted-by":"publisher","first-page":"8532","DOI":"10.1128\/jvi.76.17.8532-8539.2002","volume":"76","author":"M Weik","year":"2002","unstructured":"Weik M, Modrof J, Klenk H-D, Becker S, M\u00fchlberger E (2002) Ebola virus VP30-mediated transcription is regulated by RNA secondary structure formation. J Virol 76(17):8532\u20138539. https:\/\/doi.org\/10.1128\/jvi.76.17.8532-8539.2002","journal-title":"J Virol"},{"issue":"12","key":"4277_CR203","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1002\/jmv.24832","volume":"89","author":"G Weiwei","year":"2017","unstructured":"Weiwei G, Xuexing Z, Chong W, Yongkun Z, Qi W, Hualei W et al (2017) Marburg virus-like particles produced in insect cells induce neutralizing antibodies in rhesus macaques. J Med Virol 89(12):2069\u20132074","journal-title":"J Med Virol"},{"issue":"4","key":"4277_CR204","doi-asserted-by":"publisher","first-page":"e1000875","DOI":"10.1371\/journal.ppat.1000875","volume":"6","author":"S Welsch","year":"2010","unstructured":"Welsch S, Kolesnikova L, Kr\u00e4hling V, Riches JD, Becker S, Briggs JAG (2010) Electron tomography reveals the steps in filovirus budding. PLoS Pathog 6(4):e1000875","journal-title":"PLoS Pathog"},{"issue":"Pt 5","key":"4277_CR205","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1099\/vir.0.018226-0","volume":"91","author":"J Wenigenrath","year":"2010","unstructured":"Wenigenrath J, Kolesnikova L, Hoenen T, Mittler E, Becker S (2010) Establishment and application of an infectious virus-like particle system for Marburg virus. J Gen Virol 91(Pt 5):1325\u20131334","journal-title":"J Gen Virol"},{"key":"4277_CR206","doi-asserted-by":"publisher","first-page":"292","DOI":"10.3389\/fimmu.2017.00292","volume":"8","author":"M Wieczorek","year":"2017","unstructured":"Wieczorek M, Abualrous ET, Sticht J, \u00c1lvaro-Benito M, Stolzenberg S, No\u00e9 F et al (2017) Major histocompatibility complex (MHC) class I and MHC class II proteins: conformational plasticity in antigen presentation. Front Immunol 8:292","journal-title":"Front Immunol"},{"issue":"6","key":"4277_CR207","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.1128\/JVI.02607-15","volume":"90","author":"KJ Wijesinghe","year":"2015","unstructured":"Wijesinghe KJ, Stahelin RV (2015) Investigation of the lipid binding properties of the Marburg virus matrix protein VP40. J Virol 90(6):3074\u20133085","journal-title":"J Virol"},{"issue":"5","key":"4277_CR208","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pntd.0010433","volume":"16","author":"C Woolsey","year":"2022","unstructured":"Woolsey C, Cross RW, Agans KN, Borisevich V, Deer DJ, Geisbert JB et al (2022) A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challenge. PLoS Negl Trop Dis 16(5):1\u201327. https:\/\/doi.org\/10.1371\/journal.pntd.0010433","journal-title":"PLoS Negl Trop Dis"},{"key":"4277_CR209","unstructured":"World Health Organisation Regional Office for Africa. Ghana declares first-ever outbreak of Marburg virus disease. https:\/\/www.afro.who.int\/countries\/ghana\/news\/ghana-declares-first-ever-outbreak-marburg-virus-disease-0"},{"issue":"suppl 3","key":"4277_CR210","doi-asserted-by":"publisher","first-page":"S326","DOI":"10.1093\/infdis\/jiw250","volume":"214","author":"S Wu","year":"2016","unstructured":"Wu S, Kroeker A, Wong G, He S, Hou L, Audet J et al (2016) An adenovirus vaccine expressing Ebola virus variant makona glycoprotein is efficacious in guinea pigs and nonhuman primates. J Infect Dis 214(suppl 3):S326\u2013S332","journal-title":"J Infect Dis"},{"issue":"20","key":"4277_CR211","doi-asserted-by":"publisher","first-page":"10780","DOI":"10.1128\/JVI.77.20.10780-10789.2003","volume":"77","author":"ZQ Xiang","year":"2003","unstructured":"Xiang ZQ, Gao GP, Reyes-Sandoval A, Li Y, Wilson JM, Ertl HCJ (2003) Oral vaccination of mice with adenoviral vectors is not impaired by preexisting immunity to the vaccine carrier. J Virol 77(20):10780\u201310789","journal-title":"J Virol"},{"issue":"1","key":"4277_CR212","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/nm0198-037","volume":"4","author":"L Xu","year":"1998","unstructured":"Xu L, Sanchez A, Yang Z, Zaki SR, Nabel EG, Nichol ST et al (1998) Immunization for Ebola virus infection. Nat Med 4(1):37\u201342","journal-title":"Nat Med"},{"issue":"1","key":"4277_CR213","doi-asserted-by":"publisher","first-page":"6402","DOI":"10.1038\/s41467-020-20228-7","volume":"11","author":"Y Yahalom-Ronen","year":"2020","unstructured":"Yahalom-Ronen Y, Tamir H, Melamed S, Politi B, Shifman O, Achdout H et al (2020) A single dose of recombinant VSV-\u2206G-spike vaccine provides protection against SARS-CoV-2 challenge. Nat Commun 11(1):6402","journal-title":"Nat Commun"},{"issue":"1","key":"4277_CR214","doi-asserted-by":"publisher","first-page":"19","DOI":"10.7774\/cevr.2013.2.1.19","volume":"2","author":"D-K Yang","year":"2013","unstructured":"Yang D-K, Kim H-H, Lee K-W, Song J-Y (2013) The present and future of rabies vaccine in animals. Clin Exp Vaccine Res 2(1):19\u201325. https:\/\/doi.org\/10.7774\/cevr.2013.2.1.19","journal-title":"Clin Exp Vaccine Res"},{"key":"4277_CR215","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41551-024-01208-4","volume":"9","author":"D Yin","year":"2024","unstructured":"Yin D, Zhong Y, Ling S, Lu S, Wang X, Jiang Z et al (2024) Dendritic-cell-targeting virus-like particles as potent mRNA vaccine carriers. Nat Biomed Eng 9:185\u2013200","journal-title":"Nat Biomed Eng"},{"issue":"8","key":"4277_CR216","doi-asserted-by":"publisher","first-page":"e18059","DOI":"10.1016\/j.heliyon.2023.e18059","volume":"9","author":"H Yousaf","year":"2023","unstructured":"Yousaf H, Naz A, Zaman N, Hassan M, Obaid A, Awan FM et al (2023) Immunoinformatic and reverse vaccinology-based designing of potent multi-epitope vaccine against Marburgvirus targeting the glycoprotein. Heliyon 9(8):e18059","journal-title":"Heliyon"},{"issue":"2 Suppl","key":"4277_CR217","first-page":"23","volume":"60","author":"H Zeller","year":"2000","unstructured":"Zeller H (2000) Lessons from the Marburg virus epidemic in Durba, Democratic Republic of the Congo (1998\u20132000). Med Trop (Mars) 60(2 Suppl):23\u201326","journal-title":"Med Trop (Mars)"},{"issue":"1","key":"4277_CR218","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00430-024-00811-1","volume":"214","author":"X Zhang","year":"2024","unstructured":"Zhang X, Sun Y, Zhang J, Zhang J, Wang J, Hu C et al (2024a) Construction and evaluation of glycoprotein-based nucleic acid vaccines for Marburg virus. Med Microbiol Immunol 214(1):1. https:\/\/doi.org\/10.1007\/s00430-024-00811-1","journal-title":"Med Microbiol Immunol"},{"issue":"9","key":"4277_CR219","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.3390\/vaccines12091013","volume":"12","author":"X Zhang","year":"2024","unstructured":"Zhang X, Sun Y, Zhang J, Wei H, Wang J, Hu C et al (2024b) Lysosome-associated membrane protein targeting strategy improved immunogenicity of glycoprotein-based DNA vaccine for Marburg virus. Vaccines 12(9):1013","journal-title":"Vaccines"},{"issue":"4","key":"4277_CR220","doi-asserted-by":"publisher","first-page":"312","DOI":"10.5582\/bst.2022.01333","volume":"16","author":"F Zhao","year":"2022","unstructured":"Zhao F, He Y, Lu H (2022) Marburg virus disease: A deadly rare virus is coming. Biosci Trends 16(4):312\u2013316","journal-title":"Biosci Trends"},{"key":"4277_CR221","doi-asserted-by":"crossref","unstructured":"Zhao C, Song W, Wang J, Tang X, Jiang Z (2025) Immunoadjuvant-functionalized metal-organic frameworks: synthesis and applications in tumor immune modulation. Chem Commun (Camb)","DOI":"10.1039\/D4CC06510G"},{"issue":"8","key":"4277_CR222","doi-asserted-by":"publisher","first-page":"e13835","DOI":"10.1111\/pai.13835","volume":"33","author":"Y Zhou","year":"2022","unstructured":"Zhou Y, Li L, Yu Z, Gu X, Pan R, Li Q et al (2022) Dermatophagoides pteronyssinus allergen Der p 22: cloning, expression, IgE-binding in asthmatic children, and immunogenicity. Pediatr Allergy Immunol 33(8):e13835. https:\/\/doi.org\/10.1111\/pai.13835","journal-title":"Pediatr Allergy Immunol"},{"issue":"18","key":"4277_CR225","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/JVI.00996-17","volume":"91","author":"T Zhu","year":"2017","unstructured":"Zhu T, Song H, Peng R, Shi Y, Qi J, Gao GF (2017) Crystal structure of the Marburg virus nucleoprotein core domain chaperoned by a VP35 peptide reveals a conserved drug target for filovirus. J Virol 91(18):10\u2013128","journal-title":"J Virol"},{"issue":"7","key":"4277_CR224","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.3390\/vaccines10071004","volume":"10","author":"W Zhu","year":"2022","unstructured":"Zhu W, Liu G, Cao W, He S, Leung A, Str\u00f6her U et al (2022) A cloned recombinant vesicular stomatitis virus-vectored marburg vaccine, PHV01, protects guinea pigs from lethal Marburg virus disease. Vaccines 10(7):1004","journal-title":"Vaccines"},{"key":"4277_CR223","doi-asserted-by":"publisher","first-page":"1258188","DOI":"10.3389\/fpubh.2024.1258188","volume":"12","author":"Q Zhu","year":"2024","unstructured":"Zhu Q, Gao Y, Hu Q, Hu D, Wu X (2024) A study on the factors influencing the intention to receive booster shots of the COVID-19 vaccine in China based on the information frame effect. Front Public Health 12:1258188","journal-title":"Front Public Health"}],"container-title":["Archives of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-025-04277-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00203-025-04277-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00203-025-04277-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,31]],"date-time":"2025-03-31T22:01:49Z","timestamp":1743458509000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00203-025-04277-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,1]]},"references-count":225,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["4277"],"URL":"https:\/\/doi.org\/10.1007\/s00203-025-04277-4","relation":{},"ISSN":["0302-8933","1432-072X"],"issn-type":[{"value":"0302-8933","type":"print"},{"value":"1432-072X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,1]]},"assertion":[{"value":"2 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval statement (if relevant)"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent for publication statement (if relevant)"}}],"article-number":"74"}}